<!DOCTYPE html>
<html lang="en" dir="ltr" class="client-nojs">
<head>
<meta charset="UTF-8" />
<title>Antithrombin - Wikipedia, the free encyclopedia</title>
<meta name="generator" content="MediaWiki 1.26wmf13" />
<link rel="alternate" href="android-app://org.wikipedia/http/en.m.wikipedia.org/wiki/Antithrombin" />
<link rel="alternate" type="application/x-wiki" title="Edit this page" href="/w/index.php?title=Antithrombin&amp;action=edit" />
<link rel="edit" title="Edit this page" href="/w/index.php?title=Antithrombin&amp;action=edit" />
<link rel="apple-touch-icon" href="/static/apple-touch/wikipedia.png" />
<link rel="shortcut icon" href="/static/favicon/wikipedia.ico" />
<link rel="search" type="application/opensearchdescription+xml" href="/w/opensearch_desc.php" title="Wikipedia (en)" />
<link rel="EditURI" type="application/rsd+xml" href="//en.wikipedia.org/w/api.php?action=rsd" />
<link rel="alternate" hreflang="x-default" href="/wiki/Antithrombin" />
<link rel="copyright" href="//creativecommons.org/licenses/by-sa/3.0/" />
<link rel="alternate" type="application/atom+xml" title="Wikipedia Atom feed" href="/w/index.php?title=Special:RecentChanges&amp;feed=atom" />
<link rel="canonical" href="https://en.wikipedia.org/wiki/Antithrombin" />
<link rel="stylesheet" href="//en.wikipedia.org/w/load.php?debug=false&amp;lang=en&amp;modules=ext.uls.nojs%7Cext.visualEditor.viewPageTarget.noscript%7Cext.wikihiero%7Cmediawiki.legacy.commonPrint%2Cshared%7Cmediawiki.sectionAnchor%7Cmediawiki.skinning.interface%7Cmediawiki.ui.button%7Cskins.vector.styles%7Cwikibase.client.init&amp;only=styles&amp;skin=vector&amp;*" />
<meta name="ResourceLoaderDynamicStyles" content="" />
<link rel="stylesheet" href="//en.wikipedia.org/w/load.php?debug=false&amp;lang=en&amp;modules=site&amp;only=styles&amp;skin=vector&amp;*" />
<style>a:lang(ar),a:lang(kk-arab),a:lang(mzn),a:lang(ps),a:lang(ur){text-decoration:none}
/* cache key: global:resourceloader:filter:minify-css:7:de1ab5287c9076b96eedd3f97a84a7b6 */</style>
<script src="//en.wikipedia.org/w/load.php?debug=false&amp;lang=en&amp;modules=startup&amp;only=scripts&amp;skin=vector&amp;*"></script>
<script>if(window.mw){
mw.config.set({"wgCanonicalNamespace":"","wgCanonicalSpecialPageName":false,"wgNamespaceNumber":0,"wgPageName":"Antithrombin","wgTitle":"Antithrombin","wgCurRevisionId":659794948,"wgRevisionId":659794948,"wgArticleId":511049,"wgIsArticle":true,"wgIsRedirect":false,"wgAction":"view","wgUserName":null,"wgUserGroups":["*"],"wgCategories":["Human proteins","Articles that use a Medicine navs subtemplate","Coagulation system","Serine protease inhibitors"],"wgBreakFrames":false,"wgPageContentLanguage":"en","wgPageContentModel":"wikitext","wgSeparatorTransformTable":["",""],"wgDigitTransformTable":["",""],"wgDefaultDateFormat":"dmy","wgMonthNames":["","January","February","March","April","May","June","July","August","September","October","November","December"],"wgMonthNamesShort":["","Jan","Feb","Mar","Apr","May","Jun","Jul","Aug","Sep","Oct","Nov","Dec"],"wgRelevantPageName":"Antithrombin","wgRelevantArticleId":511049,"wgIsProbablyEditable":true,"wgRestrictionEdit":[],"wgRestrictionMove":[],"wgRedirectedFrom":"Antithrombin_deficiency,_congenital","wgMediaViewerOnClick":true,"wgMediaViewerEnabledByDefault":true,"wikilove-recipient":"","wikilove-anon":0,"wgPoweredByHHVM":true,"wgWikiEditorEnabledModules":{"toolbar":true,"dialogs":true,"hidesig":true,"preview":false,"publish":false},"wgBetaFeaturesFeatures":[],"wgVisualEditor":{"pageLanguageCode":"en","pageLanguageDir":"ltr","usePageImages":true,"usePageDescriptions":true},"wgGatherShouldShowTutorial":true,"wgGatherPageImageThumbnail":"//upload.wikimedia.org/wikipedia/commons/thumb/a/ad/Antithrombin_monomer.jpeg/72px-Antithrombin_monomer.jpeg","wgULSAcceptLanguageList":[],"wgULSCurrentAutonym":"English","wgFlaggedRevsParams":{"tags":{"status":{"levels":1,"quality":2,"pristine":3}}},"wgStableRevisionId":null,"wgCategoryTreePageCategoryOptions":"{\"mode\":0,\"hideprefix\":20,\"showcount\":true,\"namespaces\":false}","wgNoticeProject":"wikipedia","wgInternalRedirectTargetUrl":"/wiki/Antithrombin","wgWikibaseItemId":"Q416336"});
}</script><script>if(window.mw){
mw.loader.implement("user.options",function($,jQuery){mw.user.options.set({"variant":"en"});});
/* cache key: global:resourceloader:filter:minify-js:7:b2706269305541eba923c165462b22c4 */
}</script>
<script>if(window.mw){
mw.loader.implement("user.tokens",function($,jQuery){mw.user.tokens.set({"editToken":"+\\","patrolToken":"+\\","watchToken":"+\\"});});
}</script>
<script>if(window.mw){
mw.loader.load(["mediawiki.action.view.redirect","mediawiki.page.startup","mediawiki.legacy.wikibits","mediawiki.legacy.ajax","ext.centralauth.centralautologin","mmv.head","ext.imageMetrics.head","ext.visualEditor.viewPageTarget.init","ext.uls.init","ext.uls.interface","ext.centralNotice.bannerController","skins.vector.js"]);
}</script>
<link rel="dns-prefetch" href="//meta.wikimedia.org" />
<!--[if lt IE 7]><style type="text/css">body{behavior:url("/w/static/1.26wmf13/skins/Vector/csshover.min.htc")}</style><![endif]-->
</head>
<body class="mediawiki ltr sitedir-ltr ns-0 ns-subject page-Antithrombin skin-vector action-view">
		<div id="mw-page-base" class="noprint"></div>
		<div id="mw-head-base" class="noprint"></div>
		<div id="content" class="mw-body" role="main">
			<a id="top"></a>

							<div id="siteNotice"><!-- CentralNotice --></div>
						<div class="mw-indicators">
</div>
			<h1 id="firstHeading" class="firstHeading" lang="en">Antithrombin</h1>
									<div id="bodyContent" class="mw-body-content">
									<div id="siteSub">From Wikipedia, the free encyclopedia</div>
								<div id="contentSub"><span class="mw-redirectedfrom">  (Redirected from <a href="/w/index.php?title=Antithrombin_deficiency,_congenital&amp;redirect=no" title="Antithrombin deficiency, congenital">Antithrombin deficiency, congenital</a>)</span></div>
												<div id="jump-to-nav" class="mw-jump">
					Jump to:					<a href="#mw-head">navigation</a>, 					<a href="#p-search">search</a>
				</div>
				<div id="mw-content-text" lang="en" dir="ltr" class="mw-content-ltr"><table class="infobox" style="width:22em">
<tr>
<th colspan="4" style="text-align:center;font-size:125%;font-weight:bold">Serpin peptidase inhibitor, clade C (antithrombin), member 1</th>
</tr>
<tr>
<td colspan="4" style="text-align:center"><a href="/wiki/File:Antithrombin_monomer.jpeg" class="image"><img alt="Antithrombin monomer.jpeg" src="//upload.wikimedia.org/wikipedia/commons/thumb/a/ad/Antithrombin_monomer.jpeg/250px-Antithrombin_monomer.jpeg" width="250" height="345" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/a/ad/Antithrombin_monomer.jpeg/375px-Antithrombin_monomer.jpeg 1.5x, //upload.wikimedia.org/wikipedia/commons/a/ad/Antithrombin_monomer.jpeg 2x" data-file-width="398" data-file-height="550" /></a>
<div>Antithrombin <a href="/wiki/Monomer" title="Monomer">monomer</a> drawn from <span class="plainlinks"><a href="/wiki/Protein_Data_Bank" title="Protein Data Bank">PDB</a>: <a rel="nofollow" class="external text" href="http://www.rcsb.org/pdb/explore/explore.do?structureId=2ANT">2ANT</a></span>&#160;.</div>
</td>
</tr>
<tr>
<td colspan="4" style="text-align:center;background-color: #eee">
<table style="border: none; padding: 0; margin: 0; width: 100%; text-align: left">
<tr style="background-color: #ddd; text-align: center">
<th colspan="2">Available structures</th>
</tr>
<tr>
<th rowspan="2" style="background-color: #c3fdb8; width:43px"><a href="/wiki/Protein_Data_Bank" title="Protein Data Bank">PDB</a></th>
<td colspan="2" style="background-color: #eee">Ortholog search: <a rel="nofollow" class="external text" href="http://www.ebi.ac.uk/pdbe/searchResults.html?display=both&amp;term=P01008%20or%20P41361%20or%20Q543J5%20or%20P32261%20or%20Q5M7T5%20or%20Q8AYE3%20or%20Q9SH52%20or%20O04582%20or%20Q9ZQR6%20or%20O82283%20or%20Q4PSX9">PDBe</a>, <a rel="nofollow" class="external text" href="http://www.rcsb.org/pdb/search/smartSubquery.do?smartSearchSubtype=UpAccessionIdQuery&amp;accessionIdList=P01008,P41361,Q543J5,P32261,Q5M7T5,Q8AYE3,Q9SH52,O04582,Q9ZQR6,O82283,Q4PSX9">RCSB</a></td>
</tr>
<tr>
<td>
<table class="collapsible collapsed" style="border: none; padding: 0; margin: 0; width: 100%; text-align: left">
<tr style="background-color: #ddd; text-align: center">
<th colspan="2">List of PDB id codes</th>
</tr>
<tr>
<td colspan="2" style="background-color: #eee">
<p><span class="plainlinks"><a rel="nofollow" class="external text" href="http://www.rcsb.org/pdb/cgi/explore.cgi?pdbId=1ANT">1ANT</a></span>, <span class="plainlinks"><a rel="nofollow" class="external text" href="http://www.rcsb.org/pdb/cgi/explore.cgi?pdbId=1ATH">1ATH</a></span>, <span class="plainlinks"><a rel="nofollow" class="external text" href="http://www.rcsb.org/pdb/cgi/explore.cgi?pdbId=1AZX">1AZX</a></span>, <span class="plainlinks"><a rel="nofollow" class="external text" href="http://www.rcsb.org/pdb/cgi/explore.cgi?pdbId=1BR8">1BR8</a></span>, <span class="plainlinks"><a rel="nofollow" class="external text" href="http://www.rcsb.org/pdb/cgi/explore.cgi?pdbId=1DZG">1DZG</a></span>, <span class="plainlinks"><a rel="nofollow" class="external text" href="http://www.rcsb.org/pdb/cgi/explore.cgi?pdbId=1DZH">1DZH</a></span>, <span class="plainlinks"><a rel="nofollow" class="external text" href="http://www.rcsb.org/pdb/cgi/explore.cgi?pdbId=1E03">1E03</a></span>, <span class="plainlinks"><a rel="nofollow" class="external text" href="http://www.rcsb.org/pdb/cgi/explore.cgi?pdbId=1E04">1E04</a></span>, <span class="plainlinks"><a rel="nofollow" class="external text" href="http://www.rcsb.org/pdb/cgi/explore.cgi?pdbId=1E05">1E05</a></span>, <span class="plainlinks"><a rel="nofollow" class="external text" href="http://www.rcsb.org/pdb/cgi/explore.cgi?pdbId=1JVQ">1JVQ</a></span>, <span class="plainlinks"><a rel="nofollow" class="external text" href="http://www.rcsb.org/pdb/cgi/explore.cgi?pdbId=1LK6">1LK6</a></span>, <span class="plainlinks"><a rel="nofollow" class="external text" href="http://www.rcsb.org/pdb/cgi/explore.cgi?pdbId=1NQ9">1NQ9</a></span>, <span class="plainlinks"><a rel="nofollow" class="external text" href="http://www.rcsb.org/pdb/cgi/explore.cgi?pdbId=1OYH">1OYH</a></span>, <span class="plainlinks"><a rel="nofollow" class="external text" href="http://www.rcsb.org/pdb/cgi/explore.cgi?pdbId=1R1L">1R1L</a></span>, <span class="plainlinks"><a rel="nofollow" class="external text" href="http://www.rcsb.org/pdb/cgi/explore.cgi?pdbId=1SR5">1SR5</a></span>, <span class="plainlinks"><a rel="nofollow" class="external text" href="http://www.rcsb.org/pdb/cgi/explore.cgi?pdbId=1T1F">1T1F</a></span>, <span class="plainlinks"><a rel="nofollow" class="external text" href="http://www.rcsb.org/pdb/cgi/explore.cgi?pdbId=1TB6">1TB6</a></span>, <span class="plainlinks"><a rel="nofollow" class="external text" href="http://www.rcsb.org/pdb/cgi/explore.cgi?pdbId=2ANT">2ANT</a></span>, <span class="plainlinks"><a rel="nofollow" class="external text" href="http://www.rcsb.org/pdb/cgi/explore.cgi?pdbId=2B4X">2B4X</a></span>, <span class="plainlinks"><a rel="nofollow" class="external text" href="http://www.rcsb.org/pdb/cgi/explore.cgi?pdbId=2B5T">2B5T</a></span>, <span class="plainlinks"><a rel="nofollow" class="external text" href="http://www.rcsb.org/pdb/cgi/explore.cgi?pdbId=2BEH">2BEH</a></span>, <span class="plainlinks"><a rel="nofollow" class="external text" href="http://www.rcsb.org/pdb/cgi/explore.cgi?pdbId=2GD4">2GD4</a></span>, <span class="plainlinks"><a rel="nofollow" class="external text" href="http://www.rcsb.org/pdb/cgi/explore.cgi?pdbId=2HIJ">2HIJ</a></span>, <span class="plainlinks"><a rel="nofollow" class="external text" href="http://www.rcsb.org/pdb/cgi/explore.cgi?pdbId=2ZNH">2ZNH</a></span>, <span class="plainlinks"><a rel="nofollow" class="external text" href="http://www.rcsb.org/pdb/cgi/explore.cgi?pdbId=3EVJ">3EVJ</a></span>, <span class="plainlinks"><a rel="nofollow" class="external text" href="http://www.rcsb.org/pdb/cgi/explore.cgi?pdbId=3KCG">3KCG</a></span>, <span class="plainlinks"><a rel="nofollow" class="external text" href="http://www.rcsb.org/pdb/cgi/explore.cgi?pdbId=4EB1">4EB1</a></span></p>
</td>
</tr>
</table>
</td>
</tr>
</table>
</td>
</tr>
<tr>
<th colspan="4" style="text-align:center;background-color: #ddd">Identifiers</th>
</tr>
<tr>
<th scope="row" style="background-color: #c3fdb8"><a href="/wiki/Human_Genome_Organisation" title="Human Genome Organisation">Symbols</a></th>
<td colspan="3" style="background-color: #eee"><span class="plainlinks"><a rel="nofollow" class="external text" href="http://www.genenames.org/cgi-bin/gene_symbol_report?hgnc_id=775">SERPINC1</a></span>&#160;; AT3; AT3D; ATIII; THPH7</td>
</tr>
<tr>
<th scope="row" style="background-color: #c3fdb8">External IDs</th>
<td colspan="3" style="background-color: #eee"><span class="plainlinks"><a href="/wiki/Mendelian_Inheritance_in_Man" title="Mendelian Inheritance in Man" class="mw-redirect">OMIM</a>:&#160;<a rel="nofollow" class="external text" href="//omim.org/entry/107300">107300</a></span> <span class="plainlinks"><a href="/wiki/Mouse_Genome_Informatics" title="Mouse Genome Informatics">MGI</a>:&#160;<a rel="nofollow" class="external text" href="http://www.informatics.jax.org/marker/MGI:88095">88095</a></span> <span class="plainlinks"><a href="/wiki/HomoloGene" title="HomoloGene">HomoloGene</a>:&#160;<a rel="nofollow" class="external text" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=homologene&amp;dopt=HomoloGene&amp;list_uids=20139">20139</a></span> <a href="/wiki/ChEMBL" title="ChEMBL">ChEMBL</a>: <span class="plainlinks"><a rel="nofollow" class="external text" href="https://www.ebi.ac.uk/chembldb/index.php/target/inspect/CHEMBL1950">1950</a></span> <a href="/wiki/GeneCards" title="GeneCards">GeneCards</a>: <span class="plainlinks"><a rel="nofollow" class="external text" href="http://www.genecards.org/cgi-bin/carddisp.pl?id_type=entrezgene&amp;id=462">SERPINC1 Gene</a></span></td>
</tr>
<tr>
<td colspan="4" style="text-align:center;background-color: #eee">
<table class="collapsible collapsed" style="border: none; padding: 0; margin: 0; width: 100%; text-align: left">
<tr style="background-color: #ddd; text-align: center">
<th colspan="2"><a href="/wiki/Gene_ontology" title="Gene ontology">Gene ontology</a></th>
</tr>
<tr>
<th style="background-color: #c3fdb8">Molecular function</th>
<td style="background-color: #eee"><big>•</big> <span class="plainlinks"><a rel="nofollow" class="external text" href="http://amigo.geneontology.org/amigo/term/GO:0002020">protease binding</a></span><br />
<big>•</big> <span class="plainlinks"><a rel="nofollow" class="external text" href="http://amigo.geneontology.org/amigo/term/GO:0004867">serine-type endopeptidase inhibitor activity</a></span><br />
<big>•</big> <span class="plainlinks"><a rel="nofollow" class="external text" href="http://amigo.geneontology.org/amigo/term/GO:0005515">protein binding</a></span><br />
<big>•</big> <span class="plainlinks"><a rel="nofollow" class="external text" href="http://amigo.geneontology.org/amigo/term/GO:0008201">heparin binding</a></span><br /></td>
</tr>
<tr>
<th style="background-color: #c3fdb8">Cellular component</th>
<td style="background-color: #eee"><big>•</big> <span class="plainlinks"><a rel="nofollow" class="external text" href="http://amigo.geneontology.org/amigo/term/GO:0005576">extracellular region</a></span><br />
<big>•</big> <span class="plainlinks"><a rel="nofollow" class="external text" href="http://amigo.geneontology.org/amigo/term/GO:0005615">extracellular space</a></span><br />
<big>•</big> <span class="plainlinks"><a rel="nofollow" class="external text" href="http://amigo.geneontology.org/amigo/term/GO:0005886">plasma membrane</a></span><br />
<big>•</big> <span class="plainlinks"><a rel="nofollow" class="external text" href="http://amigo.geneontology.org/amigo/term/GO:0070062">extracellular exosome</a></span><br />
<big>•</big> <span class="plainlinks"><a rel="nofollow" class="external text" href="http://amigo.geneontology.org/amigo/term/GO:0072562">blood microparticle</a></span><br /></td>
</tr>
<tr>
<th style="background-color: #c3fdb8">Biological process</th>
<td style="background-color: #eee"><big>•</big> <span class="plainlinks"><a rel="nofollow" class="external text" href="http://amigo.geneontology.org/amigo/term/GO:0007584">response to nutrient</a></span><br />
<big>•</big> <span class="plainlinks"><a rel="nofollow" class="external text" href="http://amigo.geneontology.org/amigo/term/GO:0007596">blood coagulation</a></span><br />
<big>•</big> <span class="plainlinks"><a rel="nofollow" class="external text" href="http://amigo.geneontology.org/amigo/term/GO:0010951">negative regulation of endopeptidase activity</a></span><br />
<big>•</big> <span class="plainlinks"><a rel="nofollow" class="external text" href="http://amigo.geneontology.org/amigo/term/GO:0050728">negative regulation of inflammatory response</a></span><br />
<big>•</big> <span class="plainlinks"><a rel="nofollow" class="external text" href="http://amigo.geneontology.org/amigo/term/GO:2000266">regulation of blood coagulation, intrinsic pathway</a></span><br /></td>
</tr>
<tr>
<td style="background-color: #eee;text-align:center;" colspan="2">Sources: <a rel="nofollow" class="external text" href="http://amigo.geneontology.org/cgi-bin/amigo/gp-assoc.cgi?gp=UniProtKB:P01008">Amigo</a> / <a rel="nofollow" class="external text" href="http://www.ebi.ac.uk/QuickGO/GProtein?ac=P01008">QuickGO</a></td>
</tr>
</table>
</td>
</tr>
<tr>
<th colspan="4" style="text-align:center;background-color: #ddd">RNA expression pattern</th>
</tr>
<tr>
<td colspan="4" style="text-align:center;background-color: #eee"><a href="/wiki/File:PBB_GE_SERPINC1_210049_at_tn.png" class="image"><img alt="PBB GE SERPINC1 210049 at tn.png" src="//upload.wikimedia.org/wikipedia/commons/thumb/d/dd/PBB_GE_SERPINC1_210049_at_tn.png/250px-PBB_GE_SERPINC1_210049_at_tn.png" width="250" height="132" srcset="//upload.wikimedia.org/wikipedia/commons/d/dd/PBB_GE_SERPINC1_210049_at_tn.png 1.5x, //upload.wikimedia.org/wikipedia/commons/d/dd/PBB_GE_SERPINC1_210049_at_tn.png 2x" data-file-width="255" data-file-height="135" /></a></td>
</tr>
<tr>
<td colspan="4" style="text-align:center;background-color: #eee"><span class="plainlinks"><a rel="nofollow" class="external text" href="http://biogps.org/gene/462/">More reference expression data</a></span></td>
</tr>
<tr>
<th colspan="4" style="text-align:center;background-color: #ddd">Orthologs</th>
</tr>
<tr>
<th scope="row" style="background-color: #c3fdb8">Species</th>
<td><b>Human</b></td>
<td><b>Mouse</b></td>
</tr>
<tr>
<th scope="row" style="background-color: #c3fdb8"><a href="/wiki/Entrez" title="Entrez">Entrez</a></th>
<td><span class="plainlinks" style="white-space: nowrap"><a rel="nofollow" class="external text" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene&amp;cmd=retrieve&amp;dopt=default&amp;list_uids=462&amp;rn=1">462</a></span></td>
<td><span class="plainlinks" style="white-space: nowrap"><a rel="nofollow" class="external text" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene&amp;cmd=retrieve&amp;dopt=default&amp;list_uids=11905&amp;rn=1">11905</a></span></td>
</tr>
<tr>
<th scope="row" style="background-color: #c3fdb8"><a href="/wiki/Ensembl" title="Ensembl">Ensembl</a></th>
<td><span class="plainlinks" style="white-space: nowrap"><a rel="nofollow" class="external text" href="http://www.ensembl.org/Homo_sapiens/geneview?gene=ENSG00000117601;db=core">ENSG00000117601</a></span></td>
<td><span class="plainlinks" style="white-space: nowrap"><a rel="nofollow" class="external text" href="http://www.ensembl.org/Mus_musculus/geneview?gene=ENSMUSG00000026715;db=core">ENSMUSG00000026715</a></span></td>
</tr>
<tr>
<th scope="row" style="background-color: #c3fdb8"><a href="/wiki/UniProt" title="UniProt">UniProt</a></th>
<td><span class="plainlinks"><a rel="nofollow" class="external text" href="http://www.uniprot.org/uniprot/P01008">P01008</a></span></td>
<td><span class="plainlinks"><a rel="nofollow" class="external text" href="http://www.uniprot.org/uniprot/P32261">P32261</a></span></td>
</tr>
<tr>
<th scope="row" style="background-color: #c3fdb8">RefSeq (mRNA)</th>
<td><span class="plainlinks" style="white-space: nowrap"><a rel="nofollow" class="external text" href="http://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?val=NM_000488">NM_000488</a></span></td>
<td><span class="plainlinks" style="white-space: nowrap"><a rel="nofollow" class="external text" href="http://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?val=NM_080844">NM_080844</a></span></td>
</tr>
<tr>
<th scope="row" style="background-color: #c3fdb8">RefSeq (protein)</th>
<td><span class="plainlinks" style="white-space: nowrap"><a rel="nofollow" class="external text" href="http://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?val=NP_000479">NP_000479</a></span></td>
<td><span class="plainlinks" style="white-space: nowrap"><a rel="nofollow" class="external text" href="http://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?val=NP_543120">NP_543120</a></span></td>
</tr>
<tr>
<th scope="row" style="background-color: #c3fdb8">Location (UCSC)</th>
<td><span class="plainlinks" style="white-space: nowrap"><a rel="nofollow" class="external text" href="http://genome.ucsc.edu/cgi-bin/hgTracks?org=Human&amp;db=hg38&amp;position=chr1:173903804-173917378">Chr 1:<br />
173.9 – 173.92 Mb</a></span></td>
<td><span class="plainlinks" style="white-space: nowrap"><a rel="nofollow" class="external text" href="http://genome.ucsc.edu/cgi-bin/hgTracks?org=Mouse&amp;db=mm10&amp;position=chr1:160978585-161005863">Chr 1:<br />
160.98 – 161.01 Mb</a></span></td>
</tr>
<tr>
<th scope="row" style="background-color: #c3fdb8"><a href="/wiki/PubMed" title="PubMed">PubMed</a> search</th>
<td><span class="plainlinks" style="white-space: nowrap"><a rel="nofollow" class="external autonumber" href="http://www.ncbi.nlm.nih.gov/sites/entrez?db=gene&amp;cmd=Link&amp;LinkName=gene_pubmed&amp;from_uid=462">[1]</a></span></td>
<td><span class="plainlinks" style="white-space: nowrap"><a rel="nofollow" class="external autonumber" href="http://www.ncbi.nlm.nih.gov/sites/entrez?db=gene&amp;cmd=Link&amp;LinkName=gene_pubmed&amp;from_uid=11905">[2]</a></span></td>
</tr>
<tr>
<td colspan="4" style="text-align:right">
<div class="plainlinks hlist navbar mini">
<ul>
<li class="nv-view"><a href="/wiki/Template:PBB/462" title="Template:PBB/462"><span title="View this template">v</span></a></li>
<li class="nv-talk"><a href="/w/index.php?title=Template_talk:PBB/462&amp;action=edit&amp;redlink=1" class="new" title="Template talk:PBB/462 (page does not exist)"><span title="Discuss this template">t</span></a></li>
<li class="nv-edit"><a class="external text" href="//en.wikipedia.org/w/index.php?title=Template:PBB/462&amp;action=edit"><span title="Edit this template">e</span></a></li>
</ul>
</div>
</td>
</tr>
</table>
<p><b>Antithrombin</b> (AT) is a small protein molecule that inactivates several enzymes of the <a href="/wiki/Coagulation" title="Coagulation">coagulation</a> system. Antithrombin is a <a href="/wiki/Glycoprotein" title="Glycoprotein">glycoprotein</a> produced by the <a href="/wiki/Liver" title="Liver">liver</a> and consists of 432 amino acids. It contains three <a href="/wiki/Disulfide_bond" title="Disulfide bond">disulfide bonds</a> and a total of four possible <a href="/wiki/Glycosylation" title="Glycosylation">glycosylation</a> sites. α-Antithrombin is the dominant form of antithrombin found in <a href="/wiki/Blood_plasma" title="Blood plasma">blood plasma</a> and has an oligosaccharide occupying each of its four glycosylation sites. A single glycosylation site remains consistently un-occupied in the minor form of antithrombin, β-antithrombin.<sup id="cite_ref-bjork_1-0" class="reference"><a href="#cite_note-bjork-1"><span>[</span>1<span>]</span></a></sup> Its activity is increased manyfold by the <a href="/wiki/Anticoagulant" title="Anticoagulant">anticoagulant</a> drug <a href="/wiki/Heparin" title="Heparin">heparin</a>, which enhances the binding of antithrombin to <a href="/wiki/Thrombin" title="Thrombin">factor II</a> and <a href="/wiki/Factor_X" title="Factor X">factor X</a>.</p>
<p></p>
<div id="toc" class="toc">
<div id="toctitle">
<h2>Contents</h2>
</div>
<ul>
<li class="toclevel-1 tocsection-1"><a href="#Antithrombin_nomenclature"><span class="tocnumber">1</span> <span class="toctext">Antithrombin nomenclature</span></a></li>
<li class="toclevel-1 tocsection-2"><a href="#Structure"><span class="tocnumber">2</span> <span class="toctext">Structure</span></a></li>
<li class="toclevel-1 tocsection-3"><a href="#Function"><span class="tocnumber">3</span> <span class="toctext">Function</span></a></li>
<li class="toclevel-1 tocsection-4"><a href="#Antithrombin_and_heparin"><span class="tocnumber">4</span> <span class="toctext">Antithrombin and heparin</span></a>
<ul>
<li class="toclevel-2 tocsection-5"><a href="#Allosteric_activation"><span class="tocnumber">4.1</span> <span class="toctext">Allosteric activation</span></a></li>
<li class="toclevel-2 tocsection-6"><a href="#Non-allosteric_activation"><span class="tocnumber">4.2</span> <span class="toctext">Non-allosteric activation</span></a></li>
</ul>
</li>
<li class="toclevel-1 tocsection-7"><a href="#Effect_of_glycosylation_on_activity"><span class="tocnumber">5</span> <span class="toctext">Effect of glycosylation on activity</span></a></li>
<li class="toclevel-1 tocsection-8"><a href="#Role_in_disease"><span class="tocnumber">6</span> <span class="toctext">Role in disease</span></a>
<ul>
<li class="toclevel-2 tocsection-9"><a href="#Acquired_antithrombin_deficiency"><span class="tocnumber">6.1</span> <span class="toctext">Acquired antithrombin deficiency</span></a></li>
<li class="toclevel-2 tocsection-10"><a href="#Inherited_antithrombin_deficiency"><span class="tocnumber">6.2</span> <span class="toctext">Inherited antithrombin deficiency</span></a>
<ul>
<li class="toclevel-3 tocsection-11"><a href="#Type_I_antithrombin_deficiency"><span class="tocnumber">6.2.1</span> <span class="toctext">Type I antithrombin deficiency</span></a></li>
<li class="toclevel-3 tocsection-12"><a href="#Type_II_antithrombin_deficiency"><span class="tocnumber">6.2.2</span> <span class="toctext">Type II antithrombin deficiency</span></a></li>
</ul>
</li>
<li class="toclevel-2 tocsection-13"><a href="#Toponyms"><span class="tocnumber">6.3</span> <span class="toctext">Toponyms</span></a></li>
</ul>
</li>
<li class="toclevel-1 tocsection-14"><a href="#As_medication"><span class="tocnumber">7</span> <span class="toctext">As medication</span></a></li>
<li class="toclevel-1 tocsection-15"><a href="#Cleaved_and_latent_antithrombin"><span class="tocnumber">8</span> <span class="toctext">Cleaved and latent antithrombin</span></a></li>
<li class="toclevel-1 tocsection-16"><a href="#Antiangiogenic_antithrombin"><span class="tocnumber">9</span> <span class="toctext">Antiangiogenic antithrombin</span></a></li>
<li class="toclevel-1 tocsection-17"><a href="#References"><span class="tocnumber">10</span> <span class="toctext">References</span></a></li>
<li class="toclevel-1 tocsection-18"><a href="#Further_reading"><span class="tocnumber">11</span> <span class="toctext">Further reading</span></a></li>
<li class="toclevel-1 tocsection-19"><a href="#External_links"><span class="tocnumber">12</span> <span class="toctext">External links</span></a></li>
</ul>
</div>
<p></p>
<h2><span class="mw-headline" id="Antithrombin_nomenclature">Antithrombin nomenclature</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Antithrombin&amp;action=edit&amp;section=1" title="Edit section: Antithrombin nomenclature">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<p>Antithrombin is also termed <b>Antithrombin III</b> (AT III). The designations Antithrombin I through to Antithrombin IV originate in early studies carried out in the 1950s by Seegers, Johnson and Fell.<sup id="cite_ref-2" class="reference"><a href="#cite_note-2"><span>[</span>2<span>]</span></a></sup></p>
<p>Antithrombin I (AT I) refers to the absorption of <a href="/wiki/Thrombin" title="Thrombin">thrombin</a> onto <a href="/wiki/Fibrin" title="Fibrin">fibrin</a> after thrombin has activated <a href="/wiki/Fibrinogen" title="Fibrinogen">fibrinogen</a>. Antithrombin II (AT II) refers to a cofactor in plasma, which together with <a href="/wiki/Heparin" title="Heparin">heparin</a> interferes with the interaction of <a href="/wiki/Thrombin" title="Thrombin">thrombin</a> and <a href="/wiki/Fibrinogen" title="Fibrinogen">fibrinogen</a>. Antithrombin III (AT III) refers to a substance in <a href="/wiki/Blood_plasma" title="Blood plasma">plasma</a> that inactivates thrombin. Antithrombin IV (AT IV) refers to an antithrombin that becomes activated during and shortly after <a href="/wiki/Blood_coagulation" title="Blood coagulation" class="mw-redirect">blood coagulation</a>.<sup id="cite_ref-3" class="reference"><a href="#cite_note-3"><span>[</span>3<span>]</span></a></sup> Only AT III and possibly AT I are medically significant. AT III is generally referred to solely as "Antithrombin" and it is Antithrombin III that is discussed in this article.</p>
<h2><span class="mw-headline" id="Structure">Structure</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Antithrombin&amp;action=edit&amp;section=2" title="Edit section: Structure">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<div class="thumb tleft">
<div class="thumbinner" style="width:502px;"><a href="/wiki/File:Antithrombin_1.jpeg" class="image"><img alt="" src="//upload.wikimedia.org/wikipedia/commons/thumb/a/aa/Antithrombin_1.jpeg/500px-Antithrombin_1.jpeg" width="500" height="228" class="thumbimage" srcset="//upload.wikimedia.org/wikipedia/commons/a/aa/Antithrombin_1.jpeg 1.5x, //upload.wikimedia.org/wikipedia/commons/a/aa/Antithrombin_1.jpeg 2x" data-file-width="727" data-file-height="332" /></a>
<div class="thumbcaption">
<div class="magnify"><a href="/wiki/File:Antithrombin_1.jpeg" class="internal" title="Enlarge"></a></div>
<span style="font-size:100%;"><b>Figure 1.</b></span> The location of the four potential glycosylation sites within the <a href="/wiki/Tertiary_structure" title="Tertiary structure" class="mw-redirect">tertiary structure</a> of an antithrombin <a href="/wiki/Monomer" title="Monomer">monomer</a> are shown, as taken from the <a href="/wiki/Protein_data_bank" title="Protein data bank" class="mw-redirect">protein data bank</a> file <a rel="nofollow" class="external text" href="http://www.pdb.org/pdb/explore/explore.do?structureId=2ANT">2ANT</a>. In this structure only Asn 155 is glycosylated by the addition of a single <a href="/wiki/N-Acetylglucosamine" title="N-Acetylglucosamine"><i>N</i>-acetylglucosamine</a> residue.</div>
</div>
</div>
<p>Antithrombin has a <a href="/wiki/Half-life" title="Half-life">half-life</a> in <a href="/wiki/Blood_plasma" title="Blood plasma">blood plasma</a> of around 3 days.<sup id="cite_ref-4" class="reference"><a href="#cite_note-4"><span>[</span>4<span>]</span></a></sup> The normal antithrombin concentration in human <a href="/wiki/Blood_plasma" title="Blood plasma">blood plasma</a> is high at approximately 0.12&#160;mg/ml, which is equivalent to a <a href="/wiki/Concentration#Molarity" title="Concentration">molar</a> concentration of 2.3 μM.<sup id="cite_ref-5" class="reference"><a href="#cite_note-5"><span>[</span>5<span>]</span></a></sup> Antithrombin has been isolated from the plasma of a large number of species additional to humans.<sup id="cite_ref-6" class="reference"><a href="#cite_note-6"><span>[</span>6<span>]</span></a></sup> As deduced from protein and <a href="/wiki/CDNA" title="CDNA" class="mw-redirect">cDNA</a> sequencing, cow, sheep, rabbit and mouse antithrombins are all 433 amino acids in length, which is one amino acid longer than human antithrombin. The extra amino acid is thought to occur at amino acid position 6. Cow, sheep, rabbit, mouse, and human antithrombins share between 84 and 89% amino acid sequence identity.<sup id="cite_ref-olson_7-0" class="reference"><a href="#cite_note-olson-7"><span>[</span>7<span>]</span></a></sup> Six of the amino acids form three intramolecular <a href="/wiki/Disulfide_bond" title="Disulfide bond">disulfide bonds</a>, <a href="/wiki/Cysteine" title="Cysteine">Cys</a>8-Cys128, Cys21-Cys95, and Cys248-Cys430. They all have four potential <a href="/wiki/N-glycosylation" title="N-glycosylation" class="mw-redirect">N-glycosylation</a> sites. These occur at <a href="/wiki/Asparagine" title="Asparagine">asparagine</a> (Asn) amino acid numbers 96, 135, 155, and 192 in humans and at similar amino acid numbers in other species. All these sites are occupied by covalently attached oligosaccharide side-chains in the predominant form of human antithrombin, α-antithrombin, resulting in a molecular weight for this form of antithrombin of 58,200.<sup id="cite_ref-bjork_1-1" class="reference"><a href="#cite_note-bjork-1"><span>[</span>1<span>]</span></a></sup> The potential glycosylation site at asparagine 135 is not occupied in a minor form (around 10%) of antithrombin, β-antithrombin (see <b>Figure 1</b>).<sup id="cite_ref-8" class="reference"><a href="#cite_note-8"><span>[</span>8<span>]</span></a></sup></p>
<p><a href="/wiki/Recombinant_DNA" title="Recombinant DNA">Recombinant</a> antithrombins with properties similar to those of normal human antithrombin have been produced using <a href="/wiki/Baculovirus" title="Baculovirus" class="mw-redirect">baculovirus</a>-infected insect cells and mammalian cell lines grown in <a href="/wiki/Cell_culture" title="Cell culture">cell culture</a>.<sup id="cite_ref-9" class="reference"><a href="#cite_note-9"><span>[</span>9<span>]</span></a></sup><sup id="cite_ref-10" class="reference"><a href="#cite_note-10"><span>[</span>10<span>]</span></a></sup><sup id="cite_ref-11" class="reference"><a href="#cite_note-11"><span>[</span>11<span>]</span></a></sup><sup id="cite_ref-12" class="reference"><a href="#cite_note-12"><span>[</span>12<span>]</span></a></sup> These recombinant antithrombins generally have different glycosylation patterns to normal antithrombin and are typically used in antithrombin structural studies. For this reason many of the antithrombin structures stored in the <a href="/wiki/Protein_data_bank" title="Protein data bank" class="mw-redirect">protein data bank</a> and presented in this article show variable glycosylation patterns.</p>
<p>Antithrombin begins in its native state, which has a higher free energy compared to the latent state, which it decays to on average after 3 days. The latent state has the same form as the activated state - that is, when it is inhibiting thrombin. As such it is a classic example of the utility of kinetic vs thermodynamic control of protein folding.</p>
<h2><span class="mw-headline" id="Function">Function</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Antithrombin&amp;action=edit&amp;section=3" title="Edit section: Function">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<div class="thumb tleft">
<div class="thumbinner" style="width:462px;"><a href="/wiki/File:Antithrombin_2.jpeg" class="image"><img alt="" src="//upload.wikimedia.org/wikipedia/commons/thumb/d/dd/Antithrombin_2.jpeg/460px-Antithrombin_2.jpeg" width="460" height="255" class="thumbimage" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/d/dd/Antithrombin_2.jpeg/690px-Antithrombin_2.jpeg 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/d/dd/Antithrombin_2.jpeg/920px-Antithrombin_2.jpeg 2x" data-file-width="1011" data-file-height="561" /></a>
<div class="thumbcaption">
<div class="magnify"><a href="/wiki/File:Antithrombin_2.jpeg" class="internal" title="Enlarge"></a></div>
<span style="font-size:100%;"><b>Figure 2.</b></span> The reactive arg 393 - ser 394 bond is located on an exposed loop at the surface of the molecule. This loop is termed the reactive site loop (RSL) or reactive centre loop (RCL).</div>
</div>
</div>
<div class="thumb tleft">
<div class="thumbinner" style="width:462px;"><a href="/wiki/File:Antithrombin_reactive_site_loop_sequence.jpeg" class="image"><img alt="" src="//upload.wikimedia.org/wikipedia/commons/thumb/1/10/Antithrombin_reactive_site_loop_sequence.jpeg/460px-Antithrombin_reactive_site_loop_sequence.jpeg" width="460" height="41" class="thumbimage" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/1/10/Antithrombin_reactive_site_loop_sequence.jpeg/690px-Antithrombin_reactive_site_loop_sequence.jpeg 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/1/10/Antithrombin_reactive_site_loop_sequence.jpeg/920px-Antithrombin_reactive_site_loop_sequence.jpeg 2x" data-file-width="1006" data-file-height="89" /></a>
<div class="thumbcaption">
<div class="magnify"><a href="/wiki/File:Antithrombin_reactive_site_loop_sequence.jpeg" class="internal" title="Enlarge"></a></div>
<span style="font-size:100%;"><b>Figure 3.</b></span> The amino acid sequence of the reactive site loop of human antithrombin is shown.<sup id="cite_ref-Whisstock_13-0" class="reference"><a href="#cite_note-Whisstock-13"><span>[</span>13<span>]</span></a></sup> The reactive site loop comprises amino acid sequence numbers 377 to 400 (numbers shown below the above sequence) or amino acids P1 to P17 and P1' to P7' using the Schechter and Berger convention (number shown above the above sequence).<sup id="cite_ref-Schechter_14-0" class="reference"><a href="#cite_note-Schechter-14"><span>[</span>14<span>]</span></a></sup> The reactive bond is indicated by an arrow.</div>
</div>
</div>
<p>Antithrombin is a <a href="/wiki/Serine_protease_inhibitor" title="Serine protease inhibitor" class="mw-redirect">serpin</a> (serine protease inhibitor) and is thus similar in structure to most other <a href="/wiki/Blood_plasma" title="Blood plasma">plasma</a> <a href="/wiki/Protease" title="Protease">protease</a> <a href="/wiki/Enzyme_inhibitor" title="Enzyme inhibitor">inhibitors</a>, such as <a href="/wiki/Alpha_1-antichymotrypsin" title="Alpha 1-antichymotrypsin">alpha 1-antichymotrypsin</a>, <a href="/wiki/Alpha_2-antiplasmin" title="Alpha 2-antiplasmin">alpha 2-antiplasmin</a> and <a href="/wiki/Heparin_cofactor_II" title="Heparin cofactor II">Heparin cofactor II</a>.</p>
<p>The physiological target <a href="/wiki/Protease" title="Protease">proteases</a> of antithrombin are those of the <a href="/wiki/Coagulation#Contact_activation_pathway" title="Coagulation"><i>contact activation pathway</i></a> (formerly known as the intrinsic pathway), namely the activated forms of <a href="/wiki/Factor_X" title="Factor X">Factor X</a> (Xa), <a href="/wiki/Factor_IX" title="Factor IX">Factor IX</a> (IXa), <a href="/wiki/Factor_XI" title="Factor XI">Factor XI</a> (XIa), <a href="/wiki/Factor_XII" title="Factor XII">Factor XII</a> (XIIa) and, to a greater extent, <a href="/wiki/Factor_II" title="Factor II" class="mw-redirect">Factor II</a> (thrombin) (IIa), and also the activated form of <a href="/wiki/Factor_VII" title="Factor VII">Factor VII</a> (VIIa) from the <a href="/wiki/Coagulation#Tissue_factor_pathway" title="Coagulation"><i>tissue factor pathway</i></a> (formerly known as the extrinsic pathway).<sup id="cite_ref-15" class="reference"><a href="#cite_note-15"><span>[</span>15<span>]</span></a></sup> The inhibitor also inactivates <a href="/wiki/Kallikrein" title="Kallikrein">kallikrein</a> and <a href="/wiki/Plasmin" title="Plasmin">plasmin</a>, also involved in blood coagulation. However it inactivates certain other serine proteases that are not involved in coagulation such as <a href="/wiki/Trypsin" title="Trypsin">trypsin</a> and the C1s subunit of the enzyme C1 involved in the <a href="/wiki/Classical_complement_pathway" title="Classical complement pathway">classical complement pathway</a>.<sup id="cite_ref-olson_7-1" class="reference"><a href="#cite_note-olson-7"><span>[</span>7<span>]</span></a></sup><sup id="cite_ref-16" class="reference"><a href="#cite_note-16"><span>[</span>16<span>]</span></a></sup></p>
<p>Protease inactivation results as a consequence of trapping the protease in an equimolar complex with antithrombin in which the active site of the protease enzyme is inaccessible to its usual <a href="/wiki/Substrate_(biochemistry)" title="Substrate (biochemistry)" class="mw-redirect">substrate</a>.<sup id="cite_ref-olson_7-2" class="reference"><a href="#cite_note-olson-7"><span>[</span>7<span>]</span></a></sup> The formation of an antithrombin-protease complex involves an interaction between the protease and a specific reactive <a href="/wiki/Peptide_bond" title="Peptide bond">peptide bond</a> within antithrombin. In human antithrombin this bond is between <a href="/wiki/Arginine" title="Arginine">arginine</a> (arg) 393 and <a href="/wiki/Serine" title="Serine">serine</a> (ser) 394 (see <b>Figure 2</b> and <b>Figure 3</b>).<sup id="cite_ref-olson_7-3" class="reference"><a href="#cite_note-olson-7"><span>[</span>7<span>]</span></a></sup></p>
<p>It is thought that protease enzymes become trapped in inactive antithrombin-protease complexes as a consequence of their attack on the reactive bond. Although attacking a similar bond within the normal protease substrate results in rapid <a href="/wiki/Proteolytic" title="Proteolytic" class="mw-redirect">proteolytic</a> cleavage of the substrate, initiating an attack on the antithrombin reactive bond causes antithrombin to become activated and trap the enzyme at an intermediate stage of the proteolytic process. Given time, thrombin is able to cleave the reactive bond within antithrombin and an inactive antithrombin-thrombin complex will dissociate, however the time it takes for this to occur may be greater than 3 days.<sup id="cite_ref-17" class="reference"><a href="#cite_note-17"><span>[</span>17<span>]</span></a></sup> However bonds P3-P4 and P1'-P2' can be rapidly cleaved by <a href="/wiki/Neutrophil_elastase" title="Neutrophil elastase">neutrophil elastase</a> and the bacterial enzyme <a href="/wiki/Thermolysin" title="Thermolysin">thermolysin</a> respectively, resulting in inactive antithrombins no longer able to inhibit thrombin activity.<sup id="cite_ref-chang_18-0" class="reference"><a href="#cite_note-chang-18"><span>[</span>18<span>]</span></a></sup></p>
<p>The rate of antithrombin's inhibition of protease activity is greatly enhanced by its additional binding to <a href="/wiki/Heparin" title="Heparin">heparin</a> as is its inactivation by <a href="/wiki/Neutrophil_elastase" title="Neutrophil elastase">neutrophil elastase</a>.<sup id="cite_ref-chang_18-1" class="reference"><a href="#cite_note-chang-18"><span>[</span>18<span>]</span></a></sup></p>
<h2><span class="mw-headline" id="Antithrombin_and_heparin">Antithrombin and heparin</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Antithrombin&amp;action=edit&amp;section=4" title="Edit section: Antithrombin and heparin">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<p>Antithrombin inactivates its physiological target enzymes, Thrombin, Factor Xa and Factor IXa with <a href="/wiki/Rate_constant" title="Rate constant" class="mw-redirect">rate constants</a> of 7–11 x 10<sup>3</sup>, 2.5 x 10<sup>3</sup> M<sup>−1</sup> s<sup>−1</sup> and 1 x 10 M<sup>−1</sup> s<sup>−1</sup> respectively.<sup id="cite_ref-bjork_1-2" class="reference"><a href="#cite_note-bjork-1"><span>[</span>1<span>]</span></a></sup><sup id="cite_ref-bedsted_19-0" class="reference"><a href="#cite_note-bedsted-19"><span>[</span>19<span>]</span></a></sup> The rate of antithrombin-thrombin inactivation increases to 1.5 - 4 x 10<sup>7</sup> M<sup>−1</sup> s<sup>−1</sup> in the presence of heparin, i.e. the reaction is accelerated 2000-4000 fold.<sup id="cite_ref-jordan_20-0" class="reference"><a href="#cite_note-jordan-20"><span>[</span>20<span>]</span></a></sup><sup id="cite_ref-21" class="reference"><a href="#cite_note-21"><span>[</span>21<span>]</span></a></sup><sup id="cite_ref-22" class="reference"><a href="#cite_note-22"><span>[</span>22<span>]</span></a></sup><sup id="cite_ref-olson2_23-0" class="reference"><a href="#cite_note-olson2-23"><span>[</span>23<span>]</span></a></sup> Factor Xa inhibition is accelerated by only 500 to 1000 fold in the presence of heparin and the maximal rate constant is 10 fold lower than that of thrombin inhibition.<sup id="cite_ref-jordan_20-1" class="reference"><a href="#cite_note-jordan-20"><span>[</span>20<span>]</span></a></sup><sup id="cite_ref-olson2_23-1" class="reference"><a href="#cite_note-olson2-23"><span>[</span>23<span>]</span></a></sup> The rate enhancement of antithrombin-Factor IXa inhibition shows an approximate 1 million fold enhancement in the presence of heparin and physiological levels of <a href="/wiki/Calcium" title="Calcium">calcium</a>.<sup id="cite_ref-bedsted_19-1" class="reference"><a href="#cite_note-bedsted-19"><span>[</span>19<span>]</span></a></sup></p>
<p>AT-III binds to a specific pentasaccharide sulfation sequence contained within the heparin polymer</p>
<p>GlcNAc/NS(6S)-GlcA-GlcNS(3S,6S)-IdoA(2S)-GlcNS(6S)</p>
<p>Upon binding to this pentasaccharide sequence, inhibition of protease activity is increased by heparin as a result of two distinct mechanisms.<sup id="cite_ref-24" class="reference"><a href="#cite_note-24"><span>[</span>24<span>]</span></a></sup> In one mechanism heparin stimulation of Factor IXa and Xa inhibition depends on a conformational change within antithrombin involving the reactive site loop and is thus <a href="/wiki/Allosteric" title="Allosteric" class="mw-redirect">allosteric</a>.<sup id="cite_ref-Langdown_25-0" class="reference"><a href="#cite_note-Langdown-25"><span>[</span>25<span>]</span></a></sup> In another mechanism stimulation of thrombin inhibition depends on the formation of a <a href="/wiki/Ternary_complex" title="Ternary complex">ternary complex</a> between AT-III, thrombin, and heparin.<sup id="cite_ref-Langdown_25-1" class="reference"><a href="#cite_note-Langdown-25"><span>[</span>25<span>]</span></a></sup></p>
<h3><span class="mw-headline" id="Allosteric_activation">Allosteric activation</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Antithrombin&amp;action=edit&amp;section=5" title="Edit section: Allosteric activation">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<div class="thumb tleft">
<div class="thumbinner" style="width:402px;"><a href="/wiki/File:Antithrom%2Bheparin.jpeg" class="image"><img alt="" src="//upload.wikimedia.org/wikipedia/commons/thumb/f/f1/Antithrom%2Bheparin.jpeg/400px-Antithrom%2Bheparin.jpeg" width="400" height="242" class="thumbimage" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/f/f1/Antithrom%2Bheparin.jpeg/600px-Antithrom%2Bheparin.jpeg 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/f/f1/Antithrom%2Bheparin.jpeg/800px-Antithrom%2Bheparin.jpeg 2x" data-file-width="1032" data-file-height="625" /></a>
<div class="thumbcaption">
<div class="magnify"><a href="/wiki/File:Antithrom%2Bheparin.jpeg" class="internal" title="Enlarge"></a></div>
<span style="font-size:100%;"><b>Figure 4.</b></span> Two <a href="/wiki/X-ray_crystallography" title="X-ray crystallography">crystal structures</a> for antithrombin. Model <b>A</b> is taken from the <a href="/wiki/Protein_Data_Bank" title="Protein Data Bank">pdb</a> file <a rel="nofollow" class="external text" href="http://www.pdb.org/pdb/explore/explore.do?structureId=2ANT">2ANT</a> and model <b>B</b> from pdb file <a rel="nofollow" class="external text" href="http://www.pdb.org/pdb/explore/explore.do?structureId=1AZX">1AZX</a>. Model <b>B</b> is complexed with a pentasaccharide while model <b>A</b> is uncomplexed.</div>
</div>
</div>
<p>Increased Factor IXa and Xa inhibition requires the minimal heparin pentasaccharide sequence. The conformational changes that occur within antithrombin in response to pentasaccharide binding are well documented.<sup id="cite_ref-Whisstock_13-1" class="reference"><a href="#cite_note-Whisstock-13"><span>[</span>13<span>]</span></a></sup><sup id="cite_ref-Schreuder_26-0" class="reference"><a href="#cite_note-Schreuder-26"><span>[</span>26<span>]</span></a></sup><sup id="cite_ref-Carrell_27-0" class="reference"><a href="#cite_note-Carrell-27"><span>[</span>27<span>]</span></a></sup></p>
<p>In the absence of heparin, amino acids P14 and P15 (see <b>Figure 3</b>) from the reactive site loop are embedded within the main body of the protein (specifically the top of <a href="/wiki/Beta_sheet" title="Beta sheet">beta sheet</a> A). This feature is in common with other <a href="/wiki/Serpin" title="Serpin">serpins</a> such as <a href="/wiki/Heparin_cofactor_II" title="Heparin cofactor II">heparin cofactor II</a>, <a href="/wiki/Alpha_1-antichymotrypsin" title="Alpha 1-antichymotrypsin">alpha 1-antichymotrypsin</a> and <a href="/wiki/Myeloid_and_erythroid_nuclear_termination_stage_specific_protein" title="Myeloid and erythroid nuclear termination stage specific protein" class="mw-redirect">MENT</a>.</p>
<p>The conformational change most relevant for Factor IXa and Xa inhibition involves the P14 and P15 amino acids within the <a href="/wiki/N-terminus" title="N-terminus">N-terminal</a> region of the reactive site loop (circled in <b>Figure 4</b> model <b>B</b>). This region has been termed the hinge region. The conformational change within the hinge region in response to heparin binding results in the expulsion of P14 and P15 from the main body of the protein and it has been shown that by preventing this conformational change, increased Factor IXa and Xa inhibition does not occur.<sup id="cite_ref-Langdown_25-2" class="reference"><a href="#cite_note-Langdown-25"><span>[</span>25<span>]</span></a></sup> It is thought that the increased flexibility given to the reactive site loop as a result of the hinge region conformational change is a key factor in influencing increased Factor IXa and Xa inhibition. It has been calculated that in the absence of the pentasaccharide only one in every 400 Antithrombin molecules (0.25%) is in an active conformation with the P14 and P15 amino acids expelled.<sup id="cite_ref-Langdown_25-3" class="reference"><a href="#cite_note-Langdown-25"><span>[</span>25<span>]</span></a></sup></p>
<h3><span class="mw-headline" id="Non-allosteric_activation">Non-allosteric activation</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Antithrombin&amp;action=edit&amp;section=6" title="Edit section: Non-allosteric activation">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<div class="thumb tleft">
<div class="thumbinner" style="width:402px;"><a href="/wiki/File:Throm%2Banti%2Bhep_complex.jpeg" class="image"><img alt="" src="//upload.wikimedia.org/wikipedia/en/thumb/3/30/Throm%2Banti%2Bhep_complex.jpeg/400px-Throm%2Banti%2Bhep_complex.jpeg" width="400" height="316" class="thumbimage" srcset="//upload.wikimedia.org/wikipedia/en/thumb/3/30/Throm%2Banti%2Bhep_complex.jpeg/600px-Throm%2Banti%2Bhep_complex.jpeg 1.5x, //upload.wikimedia.org/wikipedia/en/thumb/3/30/Throm%2Banti%2Bhep_complex.jpeg/800px-Throm%2Banti%2Bhep_complex.jpeg 2x" data-file-width="911" data-file-height="720" /></a>
<div class="thumbcaption">
<div class="magnify"><a href="/wiki/File:Throm%2Banti%2Bhep_complex.jpeg" class="internal" title="Enlarge"></a></div>
<span style="font-size:100%;"><b>Figure 5.</b></span> The structure of an antithrombin-thrombin-heparin <a href="/wiki/Ternary_complex" title="Ternary complex">ternary complex</a> taken from pdb <a rel="nofollow" class="external text" href="http://www.pdb.org/pdb/explore/explore.do?structureId=1TB6">1TB6</a>.</div>
</div>
</div>
<p>Increased thrombin inhibition requires the minimal heparin pentasaccharide plus at least an additional 13 monomeric units.<sup id="cite_ref-28" class="reference"><a href="#cite_note-28"><span>[</span>28<span>]</span></a></sup> This is thought to be due to a requirement that antithrombin and thrombin must bind to the same heparin chain adjacent to each other. This can be seen in the series of models shown in <b>Figure 5</b>.</p>
<p>In the structures shown in Figure 5 the <a href="/wiki/C-terminus" title="C-terminus">C-terminal</a> portion (P' side) of the reactive site loop is in an extended conformation when compared with other un-activated or heparin activated antithrombin structures.<sup id="cite_ref-Li_29-0" class="reference"><a href="#cite_note-Li-29"><span>[</span>29<span>]</span></a></sup> The P' region of antithrombin is unusually long relative to the P' region of other serpins and in un-activated or heparin activated antithrombin structures forms a tightly <a href="/wiki/Hydrogen_bond" title="Hydrogen bond">hydrogen bonded</a> <a href="/wiki/Turn_(biochemistry)#Types_of_turns" title="Turn (biochemistry)">β-turn</a>. P' elongation occurs through the breaking of all hydrogen bonds involved in the <a href="/wiki/Turn_(biochemistry)#Types_of_turns" title="Turn (biochemistry)">β-turn</a>.<sup id="cite_ref-Li_29-1" class="reference"><a href="#cite_note-Li-29"><span>[</span>29<span>]</span></a></sup></p>
<p>The hinge region of antithrombin in the Figure 5 complex could not be modelled due to its conformational flexibility, and amino acids P9-P14 are not seen in this structure. This conformational flexibility indicates an <a href="/wiki/Chemical_equilibrium" title="Chemical equilibrium">equilibrium</a> may exist within the complex between a P14 P15 reactive site loop inserted antithrombin conformation and a P14 P15 reactive site loop expelled conformation. In support of this, analysis of the positioning of P15 Gly in the Figure 5 complex (labelled in model B) shows it to be inserted into <a href="/wiki/Beta_sheet" title="Beta sheet">beta sheet</a> A (see model C).<sup id="cite_ref-Li_29-2" class="reference"><a href="#cite_note-Li-29"><span>[</span>29<span>]</span></a></sup></p>
<h2><span class="mw-headline" id="Effect_of_glycosylation_on_activity">Effect of glycosylation on activity</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Antithrombin&amp;action=edit&amp;section=7" title="Edit section: Effect of glycosylation on activity">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<p>α-Antithrombin and β-antithrombin differ in their affinity for heparin.<sup id="cite_ref-mccoy_30-0" class="reference"><a href="#cite_note-mccoy-30"><span>[</span>30<span>]</span></a></sup> The difference in <a href="/wiki/Dissociation_constant" title="Dissociation constant">dissociation constant</a> between the two is threefold for the pentasaccharide shown in <b>Figure 3</b> and greater than tenfold for full length heparin, with β-antithrombin having a higher affinity.<sup id="cite_ref-31" class="reference"><a href="#cite_note-31"><span>[</span>31<span>]</span></a></sup> The higher affinity of β-antithrombin is thought to be due to the increased rate at which subsequent conformational changes occur within the protein upon initial heparin binding. For α-antithrombin, the additional glycosylation at Asn-135 is not thought to interfere with initial heparin binding, but rather to inhibit any resulting conformational changes.<sup id="cite_ref-mccoy_30-1" class="reference"><a href="#cite_note-mccoy-30"><span>[</span>30<span>]</span></a></sup></p>
<p>Even though it is present at only 5–10% the levels of α-antithrombin, due to its increased heparin affinity, it is thought that β-antithrombin is more important than α-antithrombin in controlling thrombogenic events resulting from tissue injury. Indeed, thrombin inhibition after injury to the <a href="/wiki/Aorta" title="Aorta">aorta</a> has been attributed solely to β-antithrombin.<sup id="cite_ref-32" class="reference"><a href="#cite_note-32"><span>[</span>32<span>]</span></a></sup></p>
<h2><span class="mw-headline" id="Role_in_disease">Role in disease</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Antithrombin&amp;action=edit&amp;section=8" title="Edit section: Role in disease">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<div class="hatnote">For more details on this topic, see <a href="/wiki/Antithrombin_III_deficiency" title="Antithrombin III deficiency">Antithrombin III deficiency</a>.</div>
<p>Evidence for the important role antithrombin plays in regulating normal blood coagulation is demonstrated by the correlation between <a href="/wiki/Inherited_disorder" title="Inherited disorder" class="mw-redirect">inherited</a> or <a href="/wiki/Acquired_disorder" title="Acquired disorder">acquired</a> antithrombin deficiencies and an increased risk of any affected individual developing thrombotic disease.<sup id="cite_ref-33" class="reference"><a href="#cite_note-33"><span>[</span>33<span>]</span></a></sup> <a href="/wiki/Antithrombin_deficiency" title="Antithrombin deficiency" class="mw-redirect">Antithrombin deficiency</a> generally comes to light when a patient suffers recurrent venous <a href="/wiki/Thrombosis" title="Thrombosis">thrombosis</a> and <a href="/wiki/Pulmonary_embolism" title="Pulmonary embolism">pulmonary embolism</a>.</p>
<h3><span class="mw-headline" id="Acquired_antithrombin_deficiency">Acquired antithrombin deficiency</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Antithrombin&amp;action=edit&amp;section=9" title="Edit section: Acquired antithrombin deficiency">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<p>Acquired antithrombin deficiency occurs as a result of three distinctly different mechanisms. The first mechanism is increased excretion which may occur with renal failure associated with proteinuria <a href="/wiki/Nephrotic_syndrome" title="Nephrotic syndrome">nephrotic syndrome</a>. The second mechanism results from decreased production as seen in liver failure or cirrhosis or an immature liver secondary to premature birth.<a href="/wiki/Acute_liver_failure#Coagulopathy" title="Acute liver failure">liver dysfunction (coagulopathy)</a>, <a href="/wiki/Premature_birth" title="Premature birth" class="mw-redirect">premature birth</a>. The third mechanism results from accelerated consumption which is most pronounced as consequence of severe injury <a href="/wiki/Trauma_(medicine)" title="Trauma (medicine)" class="mw-redirect">trauma</a> but also may be seen on a lesser scale as a result of interventions such as <a href="/wiki/Surgery" title="Surgery">major surgery</a> or <a href="/wiki/Cardiopulmonary_bypass" title="Cardiopulmonary bypass">cardiopulmonary bypass</a>.<sup id="cite_ref-34" class="reference"><a href="#cite_note-34"><span>[</span>34<span>]</span></a></sup></p>
<h3><span class="mw-headline" id="Inherited_antithrombin_deficiency">Inherited antithrombin deficiency</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Antithrombin&amp;action=edit&amp;section=10" title="Edit section: Inherited antithrombin deficiency">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<p>The incidence of inherited antithrombin deficiency has been estimated at between 1:2000 and 1:5000 in the normal population, with the first family suffering from inherited antithrombin deficiency being described in 1965.<sup id="cite_ref-35" class="reference"><a href="#cite_note-35"><span>[</span>35<span>]</span></a></sup><sup id="cite_ref-36" class="reference"><a href="#cite_note-36"><span>[</span>36<span>]</span></a></sup> Subsequently it was proposed that the classification of inherited antithrombin deficiency be designated as either type I or type II, based upon functional and <a href="/wiki/Immunoelectrophoresis" title="Immunoelectrophoresis">immunochemical</a> antithrombin analyses.<sup id="cite_ref-37" class="reference"><a href="#cite_note-37"><span>[</span>37<span>]</span></a></sup> Maintenance of an adequate level of antithrombin activity, which is at least 70% that of a normal functional level is essential to ensure effective inhibition of blood coagulation proteases.<sup id="cite_ref-38" class="reference"><a href="#cite_note-38"><span>[</span>38<span>]</span></a></sup> Typically as a result of type I or type II antithrombin deficiency, functional antithrombin levels are reduced to below 50% of normal.<sup id="cite_ref-Lane_39-0" class="reference"><a href="#cite_note-Lane-39"><span>[</span>39<span>]</span></a></sup></p>
<h4><span class="mw-headline" id="Type_I_antithrombin_deficiency">Type I antithrombin deficiency</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Antithrombin&amp;action=edit&amp;section=11" title="Edit section: Type I antithrombin deficiency">edit</a><span class="mw-editsection-bracket">]</span></span></h4>
<p>Type I antithrombin deficiency is characterised by a decrease in both antithrombin activity and antithrombin concentration in the blood of affected individuals. Type I deficiency was originally further divided into two subgroups, Ia and Ib, based upon heparin affinity. The antithrombin of subgroup Ia individuals showed a normal affinity for heparin while the antithrombin of subgroup Ib individuals showed a reduced affinity for heparin.<sup id="cite_ref-Sas_40-0" class="reference"><a href="#cite_note-Sas-40"><span>[</span>40<span>]</span></a></sup> Subsequent functional analysis of a group of 1b cases found them not only to have reduced heparin affinity but multiple or 'pleiotrophic' abnormalities affecting the reactive site, the heparin binding site and antithrombin blood concentration. In a revised system of classification adopted by the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis, type Ib cases are now designated as type II PE, Pleiotrophic effect.<sup id="cite_ref-database1_41-0" class="reference"><a href="#cite_note-database1-41"><span>[</span>41<span>]</span></a></sup></p>
<p>Most cases of type I deficiency are due to <a href="/wiki/Point_mutation" title="Point mutation">point mutations</a>, deletions or minor insertions within the antithrombin gene. These genetic mutations result in type I deficiency through a variety of mechanisms:</p>
<ul>
<li>Mutations may produce unstable antithrombins that either may be not exported into the blood correctly upon completion biosynthesis or exist in the blood for a shortened period of time, e.g., the deletion of 6 <a href="/wiki/Base_pair" title="Base pair">base pairs</a> in <a href="/wiki/Codon" title="Codon" class="mw-redirect">codons</a> 106-108.<sup id="cite_ref-42" class="reference"><a href="#cite_note-42"><span>[</span>42<span>]</span></a></sup></li>
<li>Mutations may affect <a href="/wiki/MRNA" title="MRNA" class="mw-redirect">mRNA</a> processing of the antithrombin gene.</li>
<li>Minor insertions or deletions may lead to <a href="/wiki/Frame_shift" title="Frame shift" class="mw-redirect">frame shift</a> mutations and premature termination of the antithrombin gene.</li>
<li>Point mutations may also result in the premature generation of a termination or <a href="/wiki/Stop_codon" title="Stop codon">stop codon</a> e.g. the mutation of codon 129, <a href="/wiki/Genetic_code#RNA_codon_table" title="Genetic code">CGA</a>→<a href="/wiki/Genetic_code#RNA_codon_table" title="Genetic code">TGA</a> (<a href="/wiki/Genetic_code#RNA_codon_table" title="Genetic code">UGA</a> after transcription), replaces a normal codon for arginine with a termination codon.<sup id="cite_ref-43" class="reference"><a href="#cite_note-43"><span>[</span>43<span>]</span></a></sup></li>
</ul>
<h4><span class="mw-headline" id="Type_II_antithrombin_deficiency">Type II antithrombin deficiency</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Antithrombin&amp;action=edit&amp;section=12" title="Edit section: Type II antithrombin deficiency">edit</a><span class="mw-editsection-bracket">]</span></span></h4>
<p>Type II antithrombin deficiency is characterised by normal antithrombin levels but reduced antithrombin activity in the blood of affected individuals. Originally it was proposed that type II deficiency be further divided into three subgroups IIa, IIb and IIc depending upon which antithrombin functional activity is reduced or retained.<sup id="cite_ref-Sas_40-1" class="reference"><a href="#cite_note-Sas-40"><span>[</span>40<span>]</span></a></sup></p>
<ul>
<li>Subgroup IIa - Decreased thrombin inactivation, decreased factor Xa inactivation and decreased heparin affinity.</li>
<li>Subgroup IIb - Decreased thrombin inactivation and normal heparin affinity.</li>
<li>Subgroup IIc - Normal thrombin inactivation, normal factor Xa inactivation and decreased heparin affinity.</li>
</ul>
<p>In the revised system of classification again adopted by the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis, type II antithrombin deficiency remains subdivided into three subgroups: the already mentioned type II PE, along with type II RS, where mutations effect the reactive site and type II HBS, where mutations effect the antithrombin heparin binding site.<sup id="cite_ref-database1_41-1" class="reference"><a href="#cite_note-database1-41"><span>[</span>41<span>]</span></a></sup> For the purposes of an antithrombin mutational database compiled by members of the Plasma Coagulation Inhibitors Subcommittee of the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis, type IIa cases are now classified as type II PE, type IIb cases as type II RS and type IIc cases as type II HBS.<sup id="cite_ref-database2_44-0" class="reference"><a href="#cite_note-database2-44"><span>[</span>44<span>]</span></a></sup></p>
<h3><span class="mw-headline" id="Toponyms">Toponyms</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Antithrombin&amp;action=edit&amp;section=13" title="Edit section: Toponyms">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<p>Presently it is relatively easy to characterise a specific antithrombin genetic mutation. However prior to the use of modern characterisation techniques investigators named mutations for the town or city where the individual suffering from the deficiency resided i.e. the antithrombin mutation was designated a <a href="/wiki/Toponym" title="Toponym" class="mw-redirect">toponym</a>.<sup id="cite_ref-Blajchman_45-0" class="reference"><a href="#cite_note-Blajchman-45"><span>[</span>45<span>]</span></a></sup> Modern mutational characterisation has since shown that many individual antithrombin toponyms are actually the result of the same genetic mutation, for example Antithrombin-Toyama, is equivalent to Antihrombin-Kumamoto, -Amien, -Tours, -Paris-1, -Paris-2, -Alger, -Padua-2 and -Barcelona.<sup id="cite_ref-database2_44-1" class="reference"><a href="#cite_note-database2-44"><span>[</span>44<span>]</span></a></sup></p>
<center>
<ul class="gallery mw-gallery-traditional">
<li class="gallerybox" style="width: 335px">
<div style="width: 335px">
<div class="thumb" style="width: 330px;">
<div style="margin:15px auto;"><a href="/wiki/File:Pleio_mutations.jpeg" class="image"><img alt="Pleio mutations.jpeg" src="//upload.wikimedia.org/wikipedia/en/thumb/1/14/Pleio_mutations.jpeg/215px-Pleio_mutations.jpeg" width="215" height="300" srcset="//upload.wikimedia.org/wikipedia/en/thumb/1/14/Pleio_mutations.jpeg/322px-Pleio_mutations.jpeg 1.5x, //upload.wikimedia.org/wikipedia/en/1/14/Pleio_mutations.jpeg 2x" data-file-width="384" data-file-height="536" /></a></div>
</div>
<div class="gallerytext"></div>
</div>
</li>
<li class="gallerybox" style="width: 335px">
<div style="width: 335px">
<div class="thumb" style="width: 330px;">
<div style="margin:15px auto;"><a href="/wiki/File:Active_site_mutations.jpeg" class="image"><img alt="Active site mutations.jpeg" src="//upload.wikimedia.org/wikipedia/en/thumb/1/1f/Active_site_mutations.jpeg/201px-Active_site_mutations.jpeg" width="201" height="300" srcset="//upload.wikimedia.org/wikipedia/en/thumb/1/1f/Active_site_mutations.jpeg/302px-Active_site_mutations.jpeg 1.5x, //upload.wikimedia.org/wikipedia/en/1/1f/Active_site_mutations.jpeg 2x" data-file-width="354" data-file-height="528" /></a></div>
</div>
<div class="gallerytext"></div>
</div>
</li>
<li class="gallerybox" style="width: 335px">
<div style="width: 335px">
<div class="thumb" style="width: 330px;">
<div style="margin:15px auto;"><a href="/wiki/File:Hep_mutations.jpeg" class="image"><img alt="Hep mutations.jpeg" src="//upload.wikimedia.org/wikipedia/en/thumb/5/5c/Hep_mutations.jpeg/273px-Hep_mutations.jpeg" width="273" height="300" srcset="//upload.wikimedia.org/wikipedia/en/thumb/5/5c/Hep_mutations.jpeg/409px-Hep_mutations.jpeg 1.5x, //upload.wikimedia.org/wikipedia/en/5/5c/Hep_mutations.jpeg 2x" data-file-width="480" data-file-height="528" /></a></div>
</div>
<div class="gallerytext"></div>
</div>
</li>
</ul>
</center>
<h2><span class="mw-headline" id="As_medication">As medication</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Antithrombin&amp;action=edit&amp;section=14" title="Edit section: As medication">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<p>Antithrombin is used as a <a href="/wiki/Biologic_medical_product" title="Biologic medical product" class="mw-redirect">protein therapeutic</a> that can be purified from human plasma<sup id="cite_ref-ThrombateLabel_46-0" class="reference"><a href="#cite_note-ThrombateLabel-46"><span>[</span>46<span>]</span></a></sup> or produced recombinantly (for example, Atryn, which is produced in the milk of <a href="/wiki/Genetic_engineering" title="Genetic engineering">genetically modified</a> goats.<sup id="cite_ref-47" class="reference"><a href="#cite_note-47"><span>[</span>47<span>]</span></a></sup><sup id="cite_ref-ATrynLabel_48-0" class="reference"><a href="#cite_note-ATrynLabel-48"><span>[</span>48<span>]</span></a></sup>)</p>
<p>Antithrombin is approved by the FDA as an <a href="/wiki/Anticoagulant" title="Anticoagulant">anticoagulant</a> for the prevention of clots before, during, or after surgery or birthing in patients with hereditary antithrombin deficiency.<sup id="cite_ref-ThrombateLabel_46-1" class="reference"><a href="#cite_note-ThrombateLabel-46"><span>[</span>46<span>]</span></a></sup><sup id="cite_ref-ATrynLabel_48-1" class="reference"><a href="#cite_note-ATrynLabel-48"><span>[</span>48<span>]</span></a></sup></p>
<h2><span class="mw-headline" id="Cleaved_and_latent_antithrombin">Cleaved and latent antithrombin</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Antithrombin&amp;action=edit&amp;section=15" title="Edit section: Cleaved and latent antithrombin">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<div class="thumb tleft">
<div class="thumbinner" style="width:302px;"><a href="/wiki/File:Latent_antithrombin.jpeg" class="image"><img alt="" src="//upload.wikimedia.org/wikipedia/en/thumb/6/6f/Latent_antithrombin.jpeg/300px-Latent_antithrombin.jpeg" width="300" height="268" class="thumbimage" srcset="//upload.wikimedia.org/wikipedia/en/thumb/6/6f/Latent_antithrombin.jpeg/450px-Latent_antithrombin.jpeg 1.5x, //upload.wikimedia.org/wikipedia/en/6/6f/Latent_antithrombin.jpeg 2x" data-file-width="593" data-file-height="529" /></a>
<div class="thumbcaption">
<div class="magnify"><a href="/wiki/File:Latent_antithrombin.jpeg" class="internal" title="Enlarge"></a></div>
<span style="font-size:100%;"><b>Figure 6.</b></span> Latent antithrombin</div>
</div>
</div>
<p>Cleavage at the reactive site results in entrapment of the thrombin protease, with movement of the cleaved reactive site loop together with the bound protease, such that the loop forms an extra sixth strand in the middle of <a href="/wiki/Beta_sheet" title="Beta sheet">beta sheet</a> A. This movement of the reactive site loop can also be induced without cleavage, with the resulting crystallographic structure being identical to that of the physiologically latent conformation of <a href="/wiki/Plasminogen_activator_inhibitor-1" title="Plasminogen activator inhibitor-1">plasminogen activator inhibitor-1</a> (PAI-1).<sup id="cite_ref-49" class="reference"><a href="#cite_note-49"><span>[</span>49<span>]</span></a></sup> For this reason the conformation of antithrombin in which the reactive site loop is incorporated uncleaved into the main body of the protein is referred to as latent antithrombin. In contrast to PAI-1 the transition for antithrombin from a normal or native conformation to a latent conformation is irreversible.</p>
<p>Native antithrombin can be converted to latent antithrombin (L-antithrombin) by heating alone or heating in the presence of <a href="/wiki/Citrate" title="Citrate">citrate</a>.<sup id="cite_ref-50" class="reference"><a href="#cite_note-50"><span>[</span>50<span>]</span></a></sup><sup id="cite_ref-51" class="reference"><a href="#cite_note-51"><span>[</span>51<span>]</span></a></sup> However, without extreme heating and at 37°C (body temperature) 10% of all antithrombin circulating in the blood is converted to the L-antithrombin over a 24-hour period.<sup id="cite_ref-52" class="reference"><a href="#cite_note-52"><span>[</span>52<span>]</span></a></sup><sup id="cite_ref-Zhou_53-0" class="reference"><a href="#cite_note-Zhou-53"><span>[</span>53<span>]</span></a></sup> The structure of L-antithrombin is shown in <b>Figure 6</b>.</p>
<p>The 3-dimensional structure of native antithrombin was first determined in 1994.<sup id="cite_ref-Schreuder_26-1" class="reference"><a href="#cite_note-Schreuder-26"><span>[</span>26<span>]</span></a></sup><sup id="cite_ref-Carrell_27-1" class="reference"><a href="#cite_note-Carrell-27"><span>[</span>27<span>]</span></a></sup> Unexpectedly the protein crystallized as a <a href="/wiki/Protein_dimer" title="Protein dimer">heterodimer</a> composed of one molecule of native antithrombin and one molecule of latent antithrombin. Latent antithrombin on formation immediately links to a molecule of native antithrombin to form the heterodimer, and it is not until the concentration of latent antithrombin exceeds 50% of the total antithrombin that it can be detected analytically.<sup id="cite_ref-Zhou_53-1" class="reference"><a href="#cite_note-Zhou-53"><span>[</span>53<span>]</span></a></sup> Not only is the latent form of antithrombin inactive against its target coagulation proteases, but its dimerisation with an otherwise active native antithrombin molecule also results in the native molecules inactivation. The physiological impact of the loss of antithrombin activity either through latent antithrombin formation or through subsequent dimer formation is exacerbated by the preference for dimerisation to occur between heparin activated β-antithrombin and latent antithrombin as opposed to α-antithrombin.<sup id="cite_ref-Zhou_53-2" class="reference"><a href="#cite_note-Zhou-53"><span>[</span>53<span>]</span></a></sup></p>
<p>A form of antithrombin that is an intermediate in the conversion between native and latent forms of antithrombin has also been isolated and this has been termed <b>prelatent antithrombin</b>.<sup id="cite_ref-54" class="reference"><a href="#cite_note-54"><span>[</span>54<span>]</span></a></sup></p>
<h2><span class="mw-headline" id="Antiangiogenic_antithrombin">Antiangiogenic antithrombin</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Antithrombin&amp;action=edit&amp;section=16" title="Edit section: Antiangiogenic antithrombin">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<p><a href="/wiki/Angiogenesis" title="Angiogenesis">Angiogenesis</a> is a physiological process involving the growth of new <a href="/wiki/Blood_vessel" title="Blood vessel">blood vessels</a> from pre-existing vessels. Under normal physiological conditions angiogenesis is tightly regulated and is controlled by a balance of <a href="/wiki/Angiogenesis#Chemical_stimulation" title="Angiogenesis">angiogenic stimulators</a> and <a href="/wiki/Angiogenesis_inhibitor" title="Angiogenesis inhibitor">angiogenic inhibitors</a>. <a href="/wiki/Tumor" title="Tumor" class="mw-redirect">Tumor</a> growth is dependent upon angiogenesis and during tumor development a sustained production of angiogenic stimulatory factors is required along with a reduction in the quantity of angiogenic inhibitory factors tumor cells produce.<sup id="cite_ref-55" class="reference"><a href="#cite_note-55"><span>[</span>55<span>]</span></a></sup> The cleaved and latent form of antithrombin potently inhibit angiogenesis and tumor growth in animal models.<sup id="cite_ref-56" class="reference"><a href="#cite_note-56"><span>[</span>56<span>]</span></a></sup> The prelatent form of antithrombin has been shown to inhibit angiogenesis <a href="/wiki/In-vitro" title="In-vitro" class="mw-redirect">in-vitro</a> but to date has not been tested in experimental animal models.</p>
<h2><span class="mw-headline" id="References">References</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Antithrombin&amp;action=edit&amp;section=17" title="Edit section: References">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<div class="reflist columns references-column-count references-column-count-2" style="-moz-column-count: 2; -webkit-column-count: 2; column-count: 2; list-style-type: decimal;">
<ol class="references">
<li id="cite_note-bjork-1"><span class="mw-cite-backlink">^ <a href="#cite_ref-bjork_1-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-bjork_1-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-bjork_1-2"><sup><i><b>c</b></i></sup></a></span> <span class="reference-text"><span class="citation book">Bjork, I; Olson, JE (1997). <i>Antithrombin, A bloody important serpin (in Chemistry and Biology of Serpins)</i>. Plenum Press. pp.&#160;17–33. <a href="/wiki/International_Standard_Book_Number" title="International Standard Book Number">ISBN</a>&#160;<a href="/wiki/Special:BookSources/0-306-45698-2" title="Special:BookSources/0-306-45698-2">0-306-45698-2</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAntithrombin&amp;rft.au=Bjork%2C+I&amp;rft.aufirst=I&amp;rft.aulast=Bjork&amp;rft.au=Olson%2C+JE&amp;rft.btitle=Antithrombin%2C+A+bloody+important+serpin+%28in+Chemistry+and+Biology+of+Serpins%29&amp;rft.date=1997&amp;rft.genre=book&amp;rft.isbn=0-306-45698-2&amp;rft.pages=17-33&amp;rft.pub=Plenum+Press&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-2"><span class="mw-cite-backlink"><b><a href="#cite_ref-2">^</a></b></span> <span class="reference-text"><span class="citation journal">Seegers WH, Johnson JF, Fell C (1954). "An antithrombin reaction to prothrombin activation". <i>Am. J. Physiol.</i> <b>176</b> (1): 97–103. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/13124503">13124503</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAntithrombin&amp;rft.atitle=An+antithrombin+reaction+to+prothrombin+activation&amp;rft.aulast=Seegers+WH%2C+Johnson+JF%2C+Fell+C&amp;rft.au=Seegers+WH%2C+Johnson+JF%2C+Fell+C&amp;rft.date=1954&amp;rft.genre=article&amp;rft_id=info%3Apmid%2F13124503&amp;rft.issue=1&amp;rft.jtitle=Am.+J.+Physiol.&amp;rft.pages=97-103&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=176" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-3"><span class="mw-cite-backlink"><b><a href="#cite_ref-3">^</a></b></span> <span class="reference-text"><span class="citation journal">Yin ET, Wessler S, Stoll PJ (1971). "Identity of plasma-activated factor X inhibitor with antithrombin 3 and heparin cofactor". <i>J. Biol. Chem.</i> <b>246</b> (11): 3712–3719. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/4102937">4102937</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAntithrombin&amp;rft.atitle=Identity+of+plasma-activated+factor+X+inhibitor+with+antithrombin+3+and+heparin+cofactor&amp;rft.aulast=Yin+ET%2C+Wessler+S%2C+Stoll+PJ&amp;rft.au=Yin+ET%2C+Wessler+S%2C+Stoll+PJ&amp;rft.date=1971&amp;rft.genre=article&amp;rft_id=info%3Apmid%2F4102937&amp;rft.issue=11&amp;rft.jtitle=J.+Biol.+Chem.&amp;rft.pages=3712-3719&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=246" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-4"><span class="mw-cite-backlink"><b><a href="#cite_ref-4">^</a></b></span> <span class="reference-text"><span class="citation journal">Collen D, Schetz J, de Cock F, Holmer E, Verstraete M (1977). "Metabolism of antithrombin III (heparin cofactor) in man: Effects of venous thrombosis of heparin administration". <i>Eur. J. Clin. Invest</i> <b>7</b> (1): 27–35. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1111%2Fj.1365-2362.1977.tb01566.x">10.1111/j.1365-2362.1977.tb01566.x</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/65284">65284</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAntithrombin&amp;rft.atitle=Metabolism+of+antithrombin+III+%28heparin+cofactor%29+in+man%3A+Effects+of+venous+thrombosis+of+heparin+administration&amp;rft.au=Collen+D%2C+Schetz+J%2C+de+Cock+F%2C+Holmer+E%2C+Verstraete+M&amp;rft.aulast=Collen+D%2C+Schetz+J%2C+de+Cock+F%2C+Holmer+E%2C+Verstraete+M&amp;rft.date=1977&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1111%2Fj.1365-2362.1977.tb01566.x&amp;rft_id=info%3Apmid%2F65284&amp;rft.issue=1&amp;rft.jtitle=Eur.+J.+Clin.+Invest&amp;rft.pages=27-35&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=7" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-5"><span class="mw-cite-backlink"><b><a href="#cite_ref-5">^</a></b></span> <span class="reference-text"><span class="citation journal">Conard J, Brosstad F, Lie Larsen M, Samama M, Abildgaard U (1983). "Molar antithrombin concentration in normal human plasma". <i>Haemostasis</i> <b>13</b> (6): 363–368. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1159%2F000214823">10.1159/000214823</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/6667903">6667903</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAntithrombin&amp;rft.atitle=Molar+antithrombin+concentration+in+normal+human+plasma&amp;rft.au=Conard+J%2C+Brosstad+F%2C+Lie+Larsen+M%2C+Samama+M%2C+Abildgaard+U&amp;rft.aulast=Conard+J%2C+Brosstad+F%2C+Lie+Larsen+M%2C+Samama+M%2C+Abildgaard+U&amp;rft.date=1983&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1159%2F000214823&amp;rft_id=info%3Apmid%2F6667903&amp;rft.issue=6&amp;rft.jtitle=Haemostasis&amp;rft.pages=363-368&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=13" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-6"><span class="mw-cite-backlink"><b><a href="#cite_ref-6">^</a></b></span> <span class="reference-text"><span class="citation journal">Jordan RE (1983). "Antithrombin in vertebrate species: Conservation of the heparin-dependent anticoagulant mechanism". <i>Arch. Biochem. Biophys</i> <b>227</b> (2): 587–595. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1016%2F0003-9861%2883%2990488-5">10.1016/0003-9861(83)90488-5</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/6607710">6607710</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAntithrombin&amp;rft.atitle=Antithrombin+in+vertebrate+species%3A+Conservation+of+the+heparin-dependent+anticoagulant+mechanism&amp;rft.au=Jordan+RE&amp;rft.aulast=Jordan+RE&amp;rft.date=1983&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1016%2F0003-9861%2883%2990488-5&amp;rft_id=info%3Apmid%2F6607710&amp;rft.issue=2&amp;rft.jtitle=Arch.+Biochem.+Biophys&amp;rft.pages=587-595&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=227" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-olson-7"><span class="mw-cite-backlink">^ <a href="#cite_ref-olson_7-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-olson_7-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-olson_7-2"><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-olson_7-3"><sup><i><b>d</b></i></sup></a></span> <span class="reference-text"><span class="citation journal">Olson ST, Björk I (1994). "Regulation of thrombin activity by antithrombin and heparin". <i>Sem. Thromb. Hemost.</i> <b>20</b> (4): 373–409. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1055%2Fs-2007-1001928">10.1055/s-2007-1001928</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/7899869">7899869</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAntithrombin&amp;rft.atitle=Regulation+of+thrombin+activity+by+antithrombin+and+heparin&amp;rft.aulast=Olson+ST%2C+Bj%C3%B6rk+I&amp;rft.au=Olson+ST%2C+Bj%C3%B6rk+I&amp;rft.date=1994&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1055%2Fs-2007-1001928&amp;rft_id=info%3Apmid%2F7899869&amp;rft.issue=4&amp;rft.jtitle=Sem.+Thromb.+Hemost.&amp;rft.pages=373-409&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=20" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-8"><span class="mw-cite-backlink"><b><a href="#cite_ref-8">^</a></b></span> <span class="reference-text"><span class="citation journal">Brennan SO, George PM, Jordan RE (1987). "Physiological variant of antithrombin-III lacks carbohydrate side-chain at Asn 135". <i>FEBS Lett</i> <b>219</b> (2): 431–436. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1016%2F0014-5793%2887%2980266-1">10.1016/0014-5793(87)80266-1</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/3609301">3609301</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAntithrombin&amp;rft.atitle=Physiological+variant+of+antithrombin-III+lacks+carbohydrate+side-chain+at+Asn+135&amp;rft.au=Brennan+SO%2C+George+PM%2C+Jordan+RE&amp;rft.aulast=Brennan+SO%2C+George+PM%2C+Jordan+RE&amp;rft.date=1987&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1016%2F0014-5793%2887%2980266-1&amp;rft_id=info%3Apmid%2F3609301&amp;rft.issue=2&amp;rft.jtitle=FEBS+Lett&amp;rft.pages=431-436&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=219" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-9"><span class="mw-cite-backlink"><b><a href="#cite_ref-9">^</a></b></span> <span class="reference-text"><span class="citation journal">Stephens AW, Siddiqui A, Hirs CH (1987). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC304981">"Expression of functionally active human antithrombin III"</a>. <i>Proceedings of the National Academy of Sciences of the United States of America</i> <b>84</b> (11): 3886–3890. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1073%2Fpnas.84.11.3886">10.1073/pnas.84.11.3886</a>. <a href="/wiki/PubMed_Central" title="PubMed Central">PMC</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC304981">304981</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/3473488">3473488</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAntithrombin&amp;rft.atitle=Expression+of+functionally+active+human+antithrombin+III&amp;rft.aulast=Stephens+AW%2C+Siddiqui+A%2C+Hirs+CH&amp;rft.au=Stephens+AW%2C+Siddiqui+A%2C+Hirs+CH&amp;rft.date=1987&amp;rft.genre=article&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC304981&amp;rft_id=info%3Adoi%2F10.1073%2Fpnas.84.11.3886&amp;rft_id=info%3Apmc%2F304981&amp;rft_id=info%3Apmid%2F3473488&amp;rft.issue=11&amp;rft.jtitle=Proceedings+of+the+National+Academy+of+Sciences+of+the+United+States+of+America&amp;rft.pages=3886-3890&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=84" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-10"><span class="mw-cite-backlink"><b><a href="#cite_ref-10">^</a></b></span> <span class="reference-text"><span class="citation journal">Zettlmeissl G, Conradt HS, Nimtz M, Karges HE (1989). "Characterization of recombinant human antithrombin III synthesized in Chinese hamster ovary cells". <i>J. Biol. Chem.</i> <b>264</b> (35): 21153–21159. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/2592368">2592368</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAntithrombin&amp;rft.atitle=Characterization+of+recombinant+human+antithrombin+III+synthesized+in+Chinese+hamster+ovary+cells&amp;rft.aulast=Zettlmeissl+G%2C+Conradt+HS%2C+Nimtz+M%2C+Karges+HE&amp;rft.au=Zettlmeissl+G%2C+Conradt+HS%2C+Nimtz+M%2C+Karges+HE&amp;rft.date=1989&amp;rft.genre=article&amp;rft_id=info%3Apmid%2F2592368&amp;rft.issue=35&amp;rft.jtitle=J.+Biol.+Chem.&amp;rft.pages=21153-21159&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=264" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-11"><span class="mw-cite-backlink"><b><a href="#cite_ref-11">^</a></b></span> <span class="reference-text"><span class="citation journal">Gillespie LS, Hillesland KK, Knauer DJ (1991). "Expression of biologically active human antithrombin III by recombinant baculovirus in Spodoptera frugiperda cells". <i>J. Biol. Chem.</i> <b>266</b> (6): 3995–4001. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/1995647">1995647</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAntithrombin&amp;rft.atitle=Expression+of+biologically+active+human+antithrombin+III+by+recombinant+baculovirus+in+Spodoptera+frugiperda+cells&amp;rft.au=Gillespie+LS%2C+Hillesland+KK%2C+Knauer+DJ&amp;rft.aulast=Gillespie+LS%2C+Hillesland+KK%2C+Knauer+DJ&amp;rft.date=1991&amp;rft.genre=article&amp;rft_id=info%3Apmid%2F1995647&amp;rft.issue=6&amp;rft.jtitle=J.+Biol.+Chem.&amp;rft.pages=3995-4001&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=266" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-12"><span class="mw-cite-backlink"><b><a href="#cite_ref-12">^</a></b></span> <span class="reference-text"><span class="citation journal">Ersdal-Badju E, Lu A, Peng X, Picard V, Zendehrouh P, Turk B, Björk I, Olson ST, Bock SC (1995). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC1135891">"Elimination of glycosylation heterogeneity affecting heparin affinity of recombinant human antithrombin III by expression of a beta-like variant in baculovirus-infected insect cells"</a>. <i>Biochem. J.</i> <b>310</b> (Pt 1): 323–330. <a href="/wiki/PubMed_Central" title="PubMed Central">PMC</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC1135891">1135891</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/7646463">7646463</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAntithrombin&amp;rft.atitle=Elimination+of+glycosylation+heterogeneity+affecting+heparin+affinity+of+recombinant+human+antithrombin+III+by+expression+of+a+beta-like+variant+in+baculovirus-infected+insect+cells&amp;rft.au=Ersdal-Badju+E%2C+Lu+A%2C+Peng+X%2C+Picard+V%2C+Zendehrouh+P%2C+Turk+B%2C+Bj%C3%B6rk+I%2C+Olson+ST%2C+Bock+SC&amp;rft.aulast=Ersdal-Badju+E%2C+Lu+A%2C+Peng+X%2C+Picard+V%2C+Zendehrouh+P%2C+Turk+B%2C+Bj%C3%B6rk+I%2C+Olson+ST%2C+Bock+SC&amp;rft.date=1995&amp;rft.genre=article&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC1135891&amp;rft_id=info%3Apmc%2F1135891&amp;rft_id=info%3Apmid%2F7646463&amp;rft.issue=Pt+1&amp;rft.jtitle=Biochem.+J.&amp;rft.pages=323-330&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=310" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-Whisstock-13"><span class="mw-cite-backlink">^ <a href="#cite_ref-Whisstock_13-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Whisstock_13-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><span class="citation journal">Whisstock JC, Pike RN. et al. (2000). "Conformational changes in serpins: II. The mechanism of activation of antithrombin by heparin". <i>J. Mol. Biol.</i> <b>301</b> (5): 1287–1305. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1006%2Fjmbi.2000.3982">10.1006/jmbi.2000.3982</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/10966821">10966821</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAntithrombin&amp;rft.atitle=Conformational+changes+in+serpins%3A+II.+The+mechanism+of+activation+of+antithrombin+by+heparin&amp;rft.aulast=Whisstock+JC%2C+Pike+RN.&amp;rft.au=Whisstock+JC%2C+Pike+RN.&amp;rft.date=2000&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1006%2Fjmbi.2000.3982&amp;rft_id=info%3Apmid%2F10966821&amp;rft.issue=5&amp;rft.jtitle=J.+Mol.+Biol.&amp;rft.pages=1287-1305&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=301" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-Schechter-14"><span class="mw-cite-backlink"><b><a href="#cite_ref-Schechter_14-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Schechter I and Berger A. (1967). "On the size of the active site in proteases. I. Papain". <i>Biochem. Biophys. Res. Commun.</i> <b>27</b> (2): 157–162. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1016%2FS0006-291X%2867%2980055-X">10.1016/S0006-291X(67)80055-X</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/6035483">6035483</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAntithrombin&amp;rft.atitle=On+the+size+of+the+active+site+in+proteases.+I.+Papain&amp;rft.aulast=Schechter+I+and+Berger+A.&amp;rft.au=Schechter+I+and+Berger+A.&amp;rft.date=1967&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1016%2FS0006-291X%2867%2980055-X&amp;rft_id=info%3Apmid%2F6035483&amp;rft.issue=2&amp;rft.jtitle=Biochem.+Biophys.+Res.+Commun.&amp;rft.pages=157-162&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=27" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-15"><span class="mw-cite-backlink"><b><a href="#cite_ref-15">^</a></b></span> <span class="reference-text"><span class="citation journal">Persson E, Bak H, Olsen OH (2001). "Substitution of valine for leucine 305 in factor VIIa increases the intrinsic enzymatic activity". <i>J. Biol. Chem.</i> <b>276</b> (31): 29195–29199. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1074%2Fjbc.M102187200">10.1074/jbc.M102187200</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/11389142">11389142</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAntithrombin&amp;rft.atitle=Substitution+of+valine+for+leucine+305+in+factor+VIIa+increases+the+intrinsic+enzymatic+activity&amp;rft.aulast=Persson+E%2C+Bak+H%2C+Olsen+OH&amp;rft.au=Persson+E%2C+Bak+H%2C+Olsen+OH&amp;rft.date=2001&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1074%2Fjbc.M102187200&amp;rft_id=info%3Apmid%2F11389142&amp;rft.issue=31&amp;rft.jtitle=J.+Biol.+Chem.&amp;rft.pages=29195-29199&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=276" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-16"><span class="mw-cite-backlink"><b><a href="#cite_ref-16">^</a></b></span> <span class="reference-text"><span class="citation journal">Ogston D, Murray J, Crawford GP (1976). "Inhibition of the activated Cls subunit of the first component of complement by antithrombin III in the presence of heparin". <i>Thromb. Res.</i> <b>9</b> (3): 217–222. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1016%2F0049-3848%2876%2990210-3">10.1016/0049-3848(76)90210-3</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/982345">982345</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAntithrombin&amp;rft.atitle=Inhibition+of+the+activated+Cls+subunit+of+the+first+component+of+complement+by+antithrombin+III+in+the+presence+of+heparin&amp;rft.aulast=Ogston+D%2C+Murray+J%2C+Crawford+GP&amp;rft.au=Ogston+D%2C+Murray+J%2C+Crawford+GP&amp;rft.date=1976&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1016%2F0049-3848%2876%2990210-3&amp;rft_id=info%3Apmid%2F982345&amp;rft.issue=3&amp;rft.jtitle=Thromb.+Res.&amp;rft.pages=217-222&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=9" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-17"><span class="mw-cite-backlink"><b><a href="#cite_ref-17">^</a></b></span> <span class="reference-text"><span class="citation journal">Danielsson A, Björk I (1980). "Slow, spontaneous dissociation of the antithrombin-thrombin complex produces a proteolytically modified form of the inhibitor". <i>FEBS Lett</i> <b>119</b> (2): 241–244. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1016%2F0014-5793%2880%2980262-6">10.1016/0014-5793(80)80262-6</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/7428936">7428936</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAntithrombin&amp;rft.atitle=Slow%2C+spontaneous+dissociation+of+the+antithrombin-thrombin+complex+produces+a+proteolytically+modified+form+of+the+inhibitor&amp;rft.au=Danielsson+A%2C+Bj%C3%B6rk+I&amp;rft.aulast=Danielsson+A%2C+Bj%C3%B6rk+I&amp;rft.date=1980&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1016%2F0014-5793%2880%2980262-6&amp;rft_id=info%3Apmid%2F7428936&amp;rft.issue=2&amp;rft.jtitle=FEBS+Lett&amp;rft.pages=241-244&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=119" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-chang-18"><span class="mw-cite-backlink">^ <a href="#cite_ref-chang_18-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-chang_18-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><span class="citation journal">Chang WS, Wardell MR, Lomas DA, Carrell RW (1996). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC1217096">"Probing serpin reactive-loop conformations by proteolytic cleavage"</a>. <i>Biochem. J.</i> <b>314</b> (2): 647–653. <a href="/wiki/PubMed_Central" title="PubMed Central">PMC</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC1217096">1217096</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/8670081">8670081</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAntithrombin&amp;rft.atitle=Probing+serpin+reactive-loop+conformations+by+proteolytic+cleavage&amp;rft.au=Chang+WS%2C+Wardell+MR%2C+Lomas+DA%2C+Carrell+RW&amp;rft.aulast=Chang+WS%2C+Wardell+MR%2C+Lomas+DA%2C+Carrell+RW&amp;rft.date=1996&amp;rft.genre=article&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC1217096&amp;rft_id=info%3Apmc%2F1217096&amp;rft_id=info%3Apmid%2F8670081&amp;rft.issue=2&amp;rft.jtitle=Biochem.+J.&amp;rft.pages=647-653&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=314" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-bedsted-19"><span class="mw-cite-backlink">^ <a href="#cite_ref-bedsted_19-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-bedsted_19-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><span class="citation journal">Bedsted T, Swanson R, Chuang YJ, Bock PE, Björk I, Olson ST (2003). "Heparin and calcium ions dramatically enhance antithrombin reactivity with factor IXa by generating new interaction exosites". <i>Biochemistry.</i> <b>42</b> (27): 8143–8152. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1021%2Fbi034363y">10.1021/bi034363y</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/12846563">12846563</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAntithrombin&amp;rft.atitle=Heparin+and+calcium+ions+dramatically+enhance+antithrombin+reactivity+with+factor+IXa+by+generating+new+interaction+exosites&amp;rft.au=Bedsted+T%2C+Swanson+R%2C+Chuang+YJ%2C+Bock+PE%2C+Bj%C3%B6rk+I%2C+Olson+ST&amp;rft.aulast=Bedsted+T%2C+Swanson+R%2C+Chuang+YJ%2C+Bock+PE%2C+Bj%C3%B6rk+I%2C+Olson+ST&amp;rft.date=2003&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1021%2Fbi034363y&amp;rft_id=info%3Apmid%2F12846563&amp;rft.issue=27&amp;rft.jtitle=Biochemistry.&amp;rft.pages=8143-8152&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=42" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-jordan-20"><span class="mw-cite-backlink">^ <a href="#cite_ref-jordan_20-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-jordan_20-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><span class="citation journal">Jordan RE, Oosta GM, Gardner WT, Rosenberg RD (1980). "The kinetics of hemostatic enzyme-antithrombin interactions in the presence of low molecular weight heparin". <i>J. Biol. Chem.</i> <b>255</b> (21): 10081–10090. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/6448846">6448846</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAntithrombin&amp;rft.atitle=The+kinetics+of+hemostatic+enzyme-antithrombin+interactions+in+the+presence+of+low+molecular+weight+heparin&amp;rft.au=Jordan+RE%2C+Oosta+GM%2C+Gardner+WT%2C+Rosenberg+RD&amp;rft.aulast=Jordan+RE%2C+Oosta+GM%2C+Gardner+WT%2C+Rosenberg+RD&amp;rft.date=1980&amp;rft.genre=article&amp;rft_id=info%3Apmid%2F6448846&amp;rft.issue=21&amp;rft.jtitle=J.+Biol.+Chem.&amp;rft.pages=10081-10090&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=255" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-21"><span class="mw-cite-backlink"><b><a href="#cite_ref-21">^</a></b></span> <span class="reference-text"><span class="citation journal">Griffith MJ (1982). "Kinetics of the heparin-enhanced antithrombin III/thrombin reaction. Evidence for a template model for the mechanism of action of heparin". <i>J. Biol. Chem.</i> <b>257</b> (13): 7360–7365. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/7085630">7085630</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAntithrombin&amp;rft.atitle=Kinetics+of+the+heparin-enhanced+antithrombin+III%2Fthrombin+reaction.+Evidence+for+a+template+model+for+the+mechanism+of+action+of+heparin&amp;rft.au=Griffith+MJ&amp;rft.aulast=Griffith+MJ&amp;rft.date=1982&amp;rft.genre=article&amp;rft_id=info%3Apmid%2F7085630&amp;rft.issue=13&amp;rft.jtitle=J.+Biol.+Chem.&amp;rft.pages=7360-7365&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=257" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-22"><span class="mw-cite-backlink"><b><a href="#cite_ref-22">^</a></b></span> <span class="reference-text"><span class="citation journal">Olson ST, Björk I (1991). "Predominant contribution of surface approximation to the mechanism of heparin acceleration of the antithrombin-thrombin reaction. Elucidation from salt concentration effects". <i>J. Biol. Chem.</i> <b>266</b> (10): 6353–6354. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/2007588">2007588</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAntithrombin&amp;rft.atitle=Predominant+contribution+of+surface+approximation+to+the+mechanism+of+heparin+acceleration+of+the+antithrombin-thrombin+reaction.+Elucidation+from+salt+concentration+effects&amp;rft.aulast=Olson+ST%2C+Bj%C3%B6rk+I&amp;rft.au=Olson+ST%2C+Bj%C3%B6rk+I&amp;rft.date=1991&amp;rft.genre=article&amp;rft_id=info%3Apmid%2F2007588&amp;rft.issue=10&amp;rft.jtitle=J.+Biol.+Chem.&amp;rft.pages=6353-6354&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=266" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-olson2-23"><span class="mw-cite-backlink">^ <a href="#cite_ref-olson2_23-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-olson2_23-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><span class="citation journal">Olson ST, Björk I, Sheffer R, Craig PA, Shore JD, Choay J (1992). "Role of the antithrombin-binding pentasaccharide in heparin acceleration of antithrombin-proteinase reactions. Resolution of the antithrombin conformational change contribution to heparin rate enhancement". <i>J. Biol. Chem.</i> <b>267</b> (18): 12528–12538. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/1618758">1618758</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAntithrombin&amp;rft.atitle=Role+of+the+antithrombin-binding+pentasaccharide+in+heparin+acceleration+of+antithrombin-proteinase+reactions.+Resolution+of+the+antithrombin+conformational+change+contribution+to+heparin+rate+enhancement&amp;rft.aulast=Olson+ST%2C+Bj%C3%B6rk+I%2C+Sheffer+R%2C+Craig+PA%2C+Shore+JD%2C+Choay+J&amp;rft.au=Olson+ST%2C+Bj%C3%B6rk+I%2C+Sheffer+R%2C+Craig+PA%2C+Shore+JD%2C+Choay+J&amp;rft.date=1992&amp;rft.genre=article&amp;rft_id=info%3Apmid%2F1618758&amp;rft.issue=18&amp;rft.jtitle=J.+Biol.+Chem.&amp;rft.pages=12528-12538&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=267" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-24"><span class="mw-cite-backlink"><b><a href="#cite_ref-24">^</a></b></span> <span class="reference-text"><span class="citation journal">Johnson DJ, Langdown J, Li W, Luis SA, Baglin TP, Huntington JA (2006). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC2679979">"Crystal structure of monomeric native antithrombin reveals a novel reactive center loop conformation"</a>. <i>J. Biol. Chem.</i> <b>281</b> (46): 35478–35486. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1074%2Fjbc.M607204200">10.1074/jbc.M607204200</a>. <a href="/wiki/PubMed_Central" title="PubMed Central">PMC</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC2679979">2679979</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/16973611">16973611</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAntithrombin&amp;rft.atitle=Crystal+structure+of+monomeric+native+antithrombin+reveals+a+novel+reactive+center+loop+conformation&amp;rft.au=Johnson+DJ%2C+Langdown+J%2C+Li+W%2C+Luis+SA%2C+Baglin+TP%2C+Huntington+JA&amp;rft.aulast=Johnson+DJ%2C+Langdown+J%2C+Li+W%2C+Luis+SA%2C+Baglin+TP%2C+Huntington+JA&amp;rft.date=2006&amp;rft.genre=article&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2679979&amp;rft_id=info%3Adoi%2F10.1074%2Fjbc.M607204200&amp;rft_id=info%3Apmc%2F2679979&amp;rft_id=info%3Apmid%2F16973611&amp;rft.issue=46&amp;rft.jtitle=J.+Biol.+Chem.&amp;rft.pages=35478-35486&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=281" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-Langdown-25"><span class="mw-cite-backlink">^ <a href="#cite_ref-Langdown_25-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Langdown_25-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-Langdown_25-2"><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-Langdown_25-3"><sup><i><b>d</b></i></sup></a></span> <span class="reference-text"><span class="citation journal">Langdown J, Johnson DJ, Baglin TP, Huntington JA (2004). "Allosteric activation of antithrombin critically depends upon hinge region extension". <i>J. Biol. Chem.</i> <b>279</b> (45): 47288–47297. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1074%2Fjbc.M408961200">10.1074/jbc.M408961200</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/15326167">15326167</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAntithrombin&amp;rft.atitle=Allosteric+activation+of+antithrombin+critically+depends+upon+hinge+region+extension&amp;rft.au=Langdown+J%2C+Johnson+DJ%2C+Baglin+TP%2C+Huntington+JA&amp;rft.aulast=Langdown+J%2C+Johnson+DJ%2C+Baglin+TP%2C+Huntington+JA&amp;rft.date=2004&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1074%2Fjbc.M408961200&amp;rft_id=info%3Apmid%2F15326167&amp;rft.issue=45&amp;rft.jtitle=J.+Biol.+Chem.&amp;rft.pages=47288-47297&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=279" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-Schreuder-26"><span class="mw-cite-backlink">^ <a href="#cite_ref-Schreuder_26-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Schreuder_26-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><span class="citation journal">Schreuder HA, de Boer B, Dijkema R, Mulders J, Theunissen HJ, Grootenhuis PD, Hol WG (1994). "The intact and cleaved human antithrombin III complex as a model for serpin-proteinase interactions". <i>Nature Structural &amp; Molecular Biology</i> <b>1</b> (1): 48–54. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1038%2Fnsb0194-48">10.1038/nsb0194-48</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/7656006">7656006</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAntithrombin&amp;rft.atitle=The+intact+and+cleaved+human+antithrombin+III+complex+as+a+model+for+serpin-proteinase+interactions&amp;rft.aulast=Schreuder+HA%2C+de+Boer+B%2C+Dijkema+R%2C+Mulders+J%2C+Theunissen+HJ%2C+Grootenhuis+PD%2C+Hol+WG&amp;rft.au=Schreuder+HA%2C+de+Boer+B%2C+Dijkema+R%2C+Mulders+J%2C+Theunissen+HJ%2C+Grootenhuis+PD%2C+Hol+WG&amp;rft.date=1994&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1038%2Fnsb0194-48&amp;rft_id=info%3Apmid%2F7656006&amp;rft.issue=1&amp;rft.jtitle=Nature+Structural+%26+Molecular+Biology&amp;rft.pages=48-54&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=1" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-Carrell-27"><span class="mw-cite-backlink">^ <a href="#cite_ref-Carrell_27-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Carrell_27-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><span class="citation journal">Carrell RW, Stein PE, Fermi G, Wardell MR (1994). "Biological implications of a 3 A structure of dimeric antithrombin". <i>Structure</i> <b>2</b> (4): 257–270. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1016%2FS0969-2126%2800%2900028-9">10.1016/S0969-2126(00)00028-9</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/8087553">8087553</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAntithrombin&amp;rft.atitle=Biological+implications+of+a+3+A+structure+of+dimeric+antithrombin&amp;rft.au=Carrell+RW%2C+Stein+PE%2C+Fermi+G%2C+Wardell+MR&amp;rft.aulast=Carrell+RW%2C+Stein+PE%2C+Fermi+G%2C+Wardell+MR&amp;rft.date=1994&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1016%2FS0969-2126%2800%2900028-9&amp;rft_id=info%3Apmid%2F8087553&amp;rft.issue=4&amp;rft.jtitle=Structure&amp;rft.pages=257-270&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=2" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-28"><span class="mw-cite-backlink"><b><a href="#cite_ref-28">^</a></b></span> <span class="reference-text"><span class="citation journal">Petitou M, Hérault JP, Bernat A, Driguez PA, Duchaussoy P, Lormeau JC, Herbert JM (1999). "Synthesis of Thrombin inhibiting Heparin mimetics without side effects". <i>Nature</i> <b>398</b> (6726): 417–422. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1038%2F18877">10.1038/18877</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/10201371">10201371</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAntithrombin&amp;rft.atitle=Synthesis+of+Thrombin+inhibiting+Heparin+mimetics+without+side+effects&amp;rft.aulast=Petitou+M%2C+H%C3%A9rault+JP%2C+Bernat+A%2C+Driguez+PA%2C+Duchaussoy+P%2C+Lormeau+JC%2C+Herbert+JM&amp;rft.au=Petitou+M%2C+H%C3%A9rault+JP%2C+Bernat+A%2C+Driguez+PA%2C+Duchaussoy+P%2C+Lormeau+JC%2C+Herbert+JM&amp;rft.date=1999&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1038%2F18877&amp;rft_id=info%3Apmid%2F10201371&amp;rft.issue=6726&amp;rft.jtitle=Nature&amp;rft.pages=417-422&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=398" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-Li-29"><span class="mw-cite-backlink">^ <a href="#cite_ref-Li_29-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Li_29-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-Li_29-2"><sup><i><b>c</b></i></sup></a></span> <span class="reference-text"><span class="citation journal">Li W, Johnson DJ, Esmon CT, Huntington JA (2004). "Structure of the antithrombin-thrombin-heparin ternary complex reveals the antithrombotic mechanism of heparin". <i>Nature Structural &amp; Molecular Biology</i> <b>11</b> (9): 857–862. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1038%2Fnsmb811">10.1038/nsmb811</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/15311269">15311269</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAntithrombin&amp;rft.atitle=Structure+of+the+antithrombin-thrombin-heparin+ternary+complex+reveals+the+antithrombotic+mechanism+of+heparin&amp;rft.aulast=Li+W%2C+Johnson+DJ%2C+Esmon+CT%2C+Huntington+JA&amp;rft.au=Li+W%2C+Johnson+DJ%2C+Esmon+CT%2C+Huntington+JA&amp;rft.date=2004&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1038%2Fnsmb811&amp;rft_id=info%3Apmid%2F15311269&amp;rft.issue=9&amp;rft.jtitle=Nature+Structural+%26+Molecular+Biology&amp;rft.pages=857-862&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=11" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-mccoy-30"><span class="mw-cite-backlink">^ <a href="#cite_ref-mccoy_30-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-mccoy_30-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><span class="citation journal">McCoy AJ, Pei XY, Skinner R, Abrahams JP, Carrell RW (2003). "Structure of beta-antithrombin and the effect of glycosylation on antithrombin's heparin affinity and activity". <i>J. Mol. Biol.</i> <b>326</b> (3): 823–833. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1016%2FS0022-2836%2802%2901382-7">10.1016/S0022-2836(02)01382-7</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/12581643">12581643</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAntithrombin&amp;rft.atitle=Structure+of+beta-antithrombin+and+the+effect+of+glycosylation+on+antithrombin%27s+heparin+affinity+and+activity&amp;rft.aulast=McCoy+AJ%2C+Pei+XY%2C+Skinner+R%2C+Abrahams+JP%2C+Carrell+RW&amp;rft.au=McCoy+AJ%2C+Pei+XY%2C+Skinner+R%2C+Abrahams+JP%2C+Carrell+RW&amp;rft.date=2003&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1016%2FS0022-2836%2802%2901382-7&amp;rft_id=info%3Apmid%2F12581643&amp;rft.issue=3&amp;rft.jtitle=J.+Mol.+Biol.&amp;rft.pages=823-833&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=326" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-31"><span class="mw-cite-backlink"><b><a href="#cite_ref-31">^</a></b></span> <span class="reference-text"><span class="citation journal">Turk B, Brieditis I, Bock SC, Olson ST, Björk I (1997). "The oligosaccharide side chain on Asn-135 of alpha-antithrombin, absent in beta-antithrombin, decreases the heparin affinity of the inhibitor by affecting the heparin-induced conformational change". <i>Biochemistry</i> <b>36</b> (22): 6682–6691. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1021%2Fbi9702492">10.1021/bi9702492</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/9184148">9184148</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAntithrombin&amp;rft.atitle=The+oligosaccharide+side+chain+on+Asn-135+of+alpha-antithrombin%2C+absent+in+beta-antithrombin%2C+decreases+the+heparin+affinity+of+the+inhibitor+by+affecting+the+heparin-induced+conformational+change&amp;rft.aulast=Turk+B%2C+Brieditis+I%2C+Bock+SC%2C+Olson+ST%2C+Bj%C3%B6rk+I&amp;rft.au=Turk+B%2C+Brieditis+I%2C+Bock+SC%2C+Olson+ST%2C+Bj%C3%B6rk+I&amp;rft.date=1997&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1021%2Fbi9702492&amp;rft_id=info%3Apmid%2F9184148&amp;rft.issue=22&amp;rft.jtitle=Biochemistry&amp;rft.pages=6682-6691&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=36" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-32"><span class="mw-cite-backlink"><b><a href="#cite_ref-32">^</a></b></span> <span class="reference-text"><span class="citation journal">Frebelius S, Isaksson S, Swedenborg J (1996). "Thrombin inhibition by antithrombin III on the subendothelium is explained by the isoform AT beta". <i>Arterioscler. Thromb. Vasc. Biol.</i> <b>16</b> (10): 1292–1297. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1161%2F01.ATV.16.10.1292">10.1161/01.ATV.16.10.1292</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/8857927">8857927</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAntithrombin&amp;rft.atitle=Thrombin+inhibition+by+antithrombin+III+on+the+subendothelium+is+explained+by+the+isoform+AT+beta&amp;rft.au=Frebelius+S%2C+Isaksson+S%2C+Swedenborg+J&amp;rft.aulast=Frebelius+S%2C+Isaksson+S%2C+Swedenborg+J&amp;rft.date=1996&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1161%2F01.ATV.16.10.1292&amp;rft_id=info%3Apmid%2F8857927&amp;rft.issue=10&amp;rft.jtitle=Arterioscler.+Thromb.+Vasc.+Biol.&amp;rft.pages=1292-1297&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=16" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-33"><span class="mw-cite-backlink"><b><a href="#cite_ref-33">^</a></b></span> <span class="reference-text"><span class="citation journal">van Boven HH, Lane DA (1997). "Antithrombin and its inherited deficiency states". <i>Semin. Hematol.</i> <b>34</b> (3): 188–204. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/9241705">9241705</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAntithrombin&amp;rft.atitle=Antithrombin+and+its+inherited+deficiency+states&amp;rft.aulast=van+Boven+HH%2C+Lane+DA&amp;rft.au=van+Boven+HH%2C+Lane+DA&amp;rft.date=1997&amp;rft.genre=article&amp;rft_id=info%3Apmid%2F9241705&amp;rft.issue=3&amp;rft.jtitle=Semin.+Hematol.&amp;rft.pages=188-204&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=34" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-34"><span class="mw-cite-backlink"><b><a href="#cite_ref-34">^</a></b></span> <span class="reference-text"><span class="citation journal">Maclean PS, Tait RC (2007). "Hereditary and acquired antithrombin deficiency: epidemiology, pathogenesis and treatment options". <i>Drugs</i> <b>67</b> (10): 1429–1440. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.2165%2F00003495-200767100-00005">10.2165/00003495-200767100-00005</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/17600391">17600391</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAntithrombin&amp;rft.atitle=Hereditary+and+acquired+antithrombin+deficiency%3A+epidemiology%2C+pathogenesis+and+treatment+options&amp;rft.aulast=Maclean+PS%2C+Tait+RC&amp;rft.au=Maclean+PS%2C+Tait+RC&amp;rft.date=2007&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.2165%2F00003495-200767100-00005&amp;rft_id=info%3Apmid%2F17600391&amp;rft.issue=10&amp;rft.jtitle=Drugs&amp;rft.pages=1429-1440&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=67" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-35"><span class="mw-cite-backlink"><b><a href="#cite_ref-35">^</a></b></span> <span class="reference-text"><span class="citation journal">Lane DA, Kunz G, Olds RJ, Thein SL (1996). "Molecular genetics of antithrombin deficiency". <i>Blood Rev.</i> <b>10</b> (2): 59–74. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1016%2FS0268-960X%2896%2990034-X">10.1016/S0268-960X(96)90034-X</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/8813337">8813337</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAntithrombin&amp;rft.atitle=Molecular+genetics+of+antithrombin+deficiency&amp;rft.au=Lane+DA%2C+Kunz+G%2C+Olds+RJ%2C+Thein+SL&amp;rft.aulast=Lane+DA%2C+Kunz+G%2C+Olds+RJ%2C+Thein+SL&amp;rft.date=1996&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1016%2FS0268-960X%2896%2990034-X&amp;rft_id=info%3Apmid%2F8813337&amp;rft.issue=2&amp;rft.jtitle=Blood+Rev.&amp;rft.pages=59-74&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=10" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-36"><span class="mw-cite-backlink"><b><a href="#cite_ref-36">^</a></b></span> <span class="reference-text"><span class="citation journal">Egeberg O (1965). "Inherited antithrombin deficiency causing thrombophilia". <i>Thromb. Diath. Haemorrh.</i> <b>13</b>: 516–530. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/14347873">14347873</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAntithrombin&amp;rft.atitle=Inherited+antithrombin+deficiency+causing+thrombophilia&amp;rft.au=Egeberg+O&amp;rft.aulast=Egeberg+O&amp;rft.date=1965&amp;rft.genre=article&amp;rft_id=info%3Apmid%2F14347873&amp;rft.jtitle=Thromb.+Diath.+Haemorrh.&amp;rft.pages=516-530&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=13" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-37"><span class="mw-cite-backlink"><b><a href="#cite_ref-37">^</a></b></span> <span class="reference-text"><span class="citation journal">Sas G, Petö I, Bánhegyi D, Blaskó G, Domján G (1980). "Heterogeneity of the "classical" antithrombin III deficiency". <i>Thromb. Haemost.</i> <b>43</b> (2): 133–136. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/7455972">7455972</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAntithrombin&amp;rft.atitle=Heterogeneity+of+the+%22classical%22+antithrombin+III+deficiency&amp;rft.aulast=Sas+G%2C+Pet%C3%B6+I%2C+B%C3%A1nhegyi+D%2C+Blask%C3%B3+G%2C+Domj%C3%A1n+G&amp;rft.au=Sas+G%2C+Pet%C3%B6+I%2C+B%C3%A1nhegyi+D%2C+Blask%C3%B3+G%2C+Domj%C3%A1n+G&amp;rft.date=1980&amp;rft.genre=article&amp;rft_id=info%3Apmid%2F7455972&amp;rft.issue=2&amp;rft.jtitle=Thromb.+Haemost.&amp;rft.pages=133-136&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=43" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-38"><span class="mw-cite-backlink"><b><a href="#cite_ref-38">^</a></b></span> <span class="reference-text"><span class="citation journal">Lane DA, Olds RJ, Conard J, Boisclair M, Bock SC, Hultin M, Abildgaard U, Ireland H, Thompson E, Sas G (1992). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC443398">"Pleiotropic effects of antithrombin strand 1C substitution mutations"</a>. <i>J. Clin. Invest.</i> <b>90</b> (6): 2422–2433. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1172%2FJCI116133">10.1172/JCI116133</a>. <a href="/wiki/PubMed_Central" title="PubMed Central">PMC</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC443398">443398</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/1469094">1469094</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAntithrombin&amp;rft.atitle=Pleiotropic+effects+of+antithrombin+strand+1C+substitution+mutations&amp;rft.au=Lane+DA%2C+Olds+RJ%2C+Conard+J%2C+Boisclair+M%2C+Bock+SC%2C+Hultin+M%2C+Abildgaard+U%2C+Ireland+H%2C+Thompson+E%2C+Sas+G&amp;rft.aulast=Lane+DA%2C+Olds+RJ%2C+Conard+J%2C+Boisclair+M%2C+Bock+SC%2C+Hultin+M%2C+Abildgaard+U%2C+Ireland+H%2C+Thompson+E%2C+Sas+G&amp;rft.date=1992&amp;rft.genre=article&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC443398&amp;rft_id=info%3Adoi%2F10.1172%2FJCI116133&amp;rft_id=info%3Apmc%2F443398&amp;rft_id=info%3Apmid%2F1469094&amp;rft.issue=6&amp;rft.jtitle=J.+Clin.+Invest.&amp;rft.pages=2422-2433&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=90" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-Lane-39"><span class="mw-cite-backlink"><b><a href="#cite_ref-Lane_39-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Lane DA, Olds RJ, Thein SL (1994). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC308318">"Antithrombin III: summary of first database update"</a>. <i>Nucleic Acids Res.</i> <b>22</b> (17): 3556–3559. <a href="/wiki/PubMed_Central" title="PubMed Central">PMC</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC308318">308318</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/7937056">7937056</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAntithrombin&amp;rft.atitle=Antithrombin+III%3A+summary+of+first+database+update&amp;rft.au=Lane+DA%2C+Olds+RJ%2C+Thein+SL&amp;rft.aulast=Lane+DA%2C+Olds+RJ%2C+Thein+SL&amp;rft.date=1994&amp;rft.genre=article&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC308318&amp;rft_id=info%3Apmc%2F308318&amp;rft_id=info%3Apmid%2F7937056&amp;rft.issue=17&amp;rft.jtitle=Nucleic+Acids+Res.&amp;rft.pages=3556-3559&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=22" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-Sas-40"><span class="mw-cite-backlink">^ <a href="#cite_ref-Sas_40-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Sas_40-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><span class="citation journal">Sas G (1984). "Hereditary antithrombin III deficiency: biochemical aspects". <i>Haematologia</i> <b>17</b> (1): 81–86. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/6724355">6724355</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAntithrombin&amp;rft.atitle=Hereditary+antithrombin+III+deficiency%3A+biochemical+aspects&amp;rft.aulast=Sas+G&amp;rft.au=Sas+G&amp;rft.date=1984&amp;rft.genre=article&amp;rft_id=info%3Apmid%2F6724355&amp;rft.issue=1&amp;rft.jtitle=Haematologia&amp;rft.pages=81-86&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=17" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-database1-41"><span class="mw-cite-backlink">^ <a href="#cite_ref-database1_41-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-database1_41-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><span class="citation journal">Lane DA, Olds RJ, Boisclair M, Chowdhury V, Thein SL, Cooper DN, Blajchman M, Perry D, Emmerich J, Aiach M (1993). "Antithrombin III mutation database: first update. For the Thrombin and its Inhibitors Subcommittee of the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis". <i>Thromb. Haemost.</i> <b>70</b> (2): 361–369. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/8236149">8236149</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAntithrombin&amp;rft.atitle=Antithrombin+III+mutation+database%3A+first+update.+For+the+Thrombin+and+its+Inhibitors+Subcommittee+of+the+Scientific+and+Standardization+Committee+of+the+International+Society+on+Thrombosis+and+Haemostasis&amp;rft.au=Lane+DA%2C+Olds+RJ%2C+Boisclair+M%2C+Chowdhury+V%2C+Thein+SL%2C+Cooper+DN%2C+Blajchman+M%2C+Perry+D%2C+Emmerich+J%2C+Aiach+M&amp;rft.aulast=Lane+DA%2C+Olds+RJ%2C+Boisclair+M%2C+Chowdhury+V%2C+Thein+SL%2C+Cooper+DN%2C+Blajchman+M%2C+Perry+D%2C+Emmerich+J%2C+Aiach+M&amp;rft.date=1993&amp;rft.genre=article&amp;rft_id=info%3Apmid%2F8236149&amp;rft.issue=2&amp;rft.jtitle=Thromb.+Haemost.&amp;rft.pages=361-369&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=70" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-42"><span class="mw-cite-backlink"><b><a href="#cite_ref-42">^</a></b></span> <span class="reference-text"><span class="citation journal">Olds RJ, Lane DA, Beresford CH, Abildgaard U, Hughes PM, Thein SL (1993). "A recurrent deletion in the antithrombin gene, AT106-108(-6 bp), identified by DNA heteroduplex detection". <i>Genomics</i> <b>16</b> (1): 298–299. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1006%2Fgeno.1993.1184">10.1006/geno.1993.1184</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/8486379">8486379</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAntithrombin&amp;rft.atitle=A+recurrent+deletion+in+the+antithrombin+gene%2C+AT106-108%28-6+bp%29%2C+identified+by+DNA+heteroduplex+detection&amp;rft.aulast=Olds+RJ%2C+Lane+DA%2C+Beresford+CH%2C+Abildgaard+U%2C+Hughes+PM%2C+Thein+SL&amp;rft.au=Olds+RJ%2C+Lane+DA%2C+Beresford+CH%2C+Abildgaard+U%2C+Hughes+PM%2C+Thein+SL&amp;rft.date=1993&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1006%2Fgeno.1993.1184&amp;rft_id=info%3Apmid%2F8486379&amp;rft.issue=1&amp;rft.jtitle=Genomics&amp;rft.pages=298-299&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=16" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-43"><span class="mw-cite-backlink"><b><a href="#cite_ref-43">^</a></b></span> <span class="reference-text"><span class="citation journal">Olds RJ, Lane DA, Ireland H, Finazzi G, Barbui T, Abildgaard U, Girolami A, Thein SL (1991). "A common point mutation producing type 1A antithrombin III deficiency: AT129 CGA to TGA (Arg to Stop)". <i>Thromb. Res.</i> <b>64</b> (5): 621–625. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1016%2FS0049-3848%2805%2980011-8">10.1016/S0049-3848(05)80011-8</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/1808766">1808766</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAntithrombin&amp;rft.atitle=A+common+point+mutation+producing+type+1A+antithrombin+III+deficiency%3A+AT129+CGA+to+TGA+%28Arg+to+Stop%29&amp;rft.aulast=Olds+RJ%2C+Lane+DA%2C+Ireland+H%2C+Finazzi+G%2C+Barbui+T%2C+Abildgaard+U%2C+Girolami+A%2C+Thein+SL&amp;rft.au=Olds+RJ%2C+Lane+DA%2C+Ireland+H%2C+Finazzi+G%2C+Barbui+T%2C+Abildgaard+U%2C+Girolami+A%2C+Thein+SL&amp;rft.date=1991&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1016%2FS0049-3848%2805%2980011-8&amp;rft_id=info%3Apmid%2F1808766&amp;rft.issue=5&amp;rft.jtitle=Thromb.+Res.&amp;rft.pages=621-625&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=64" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-database2-44"><span class="mw-cite-backlink">^ <a href="#cite_ref-database2_44-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-database2_44-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text">Imperial College London, Faculty of Medicine, <a rel="nofollow" class="external text" href="http://www1.imperial.ac.uk/medicine/about/divisions/is/haemo/coag/antithrombin/">Antithrombin Mutation Database</a>. Retrieved on 2008-08-16.</span></li>
<li id="cite_note-Blajchman-45"><span class="mw-cite-backlink"><b><a href="#cite_ref-Blajchman_45-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Blajchman MA, Austin RC, Fernandez-Rachubinski F, Sheffield WP (1992). "Molecular basis of inherited human antithrombin deficiency". <i>Blood</i> <b>80</b> (9): 2159–2171. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/1421387">1421387</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAntithrombin&amp;rft.atitle=Molecular+basis+of+inherited+human+antithrombin+deficiency&amp;rft.au=Blajchman+MA%2C+Austin+RC%2C+Fernandez-Rachubinski+F%2C+Sheffield+WP&amp;rft.aulast=Blajchman+MA%2C+Austin+RC%2C+Fernandez-Rachubinski+F%2C+Sheffield+WP&amp;rft.date=1992&amp;rft.genre=article&amp;rft_id=info%3Apmid%2F1421387&amp;rft.issue=9&amp;rft.jtitle=Blood&amp;rft.pages=2159-2171&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=80" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-ThrombateLabel-46"><span class="mw-cite-backlink">^ <a href="#cite_ref-ThrombateLabel_46-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-ThrombateLabel_46-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><a rel="nofollow" class="external text" href="http://www.talecris-pi.info/inserts/thrombate.pdf">Thrombate III label</a></span></li>
<li id="cite_note-47"><span class="mw-cite-backlink"><b><a href="#cite_ref-47">^</a></b></span> <span class="reference-text"><a rel="nofollow" class="external text" href="http://www.fda.gov/BiologicsBloodVaccines/BloodBloodProducts/ApprovedProducts/LicensedProductsBLAs/FractionatedPlasmaProducts/ucm134042.htm">FDA website for ATryn (BL 125284)</a></span></li>
<li id="cite_note-ATrynLabel-48"><span class="mw-cite-backlink">^ <a href="#cite_ref-ATrynLabel_48-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-ATrynLabel_48-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><a rel="nofollow" class="external text" href="http://www.fda.gov/downloads/BiologicsBloodVaccines/BloodBloodProducts/ApprovedProducts/LicensedProductsBLAs/FractionatedPlasmaProducts/UCM134045.pdf">Antithrombin (Recombinant) US Package Insert ATryn for Injection February 3, 2009</a></span></li>
<li id="cite_note-49"><span class="mw-cite-backlink"><b><a href="#cite_ref-49">^</a></b></span> <span class="reference-text"><span class="citation journal">Mottonen J, Strand A, Symersky J, Sweet RM, Danley DE, Geoghegan KF, Gerard RD, Goldsmith EJ (1992). "Structural basis of latency in plasminogen activator inhibitor-1". <i>Nature</i> <b>355</b> (6357): 270–273. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1038%2F355270a0">10.1038/355270a0</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/1731226">1731226</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAntithrombin&amp;rft.atitle=Structural+basis+of+latency+in+plasminogen+activator+inhibitor-1&amp;rft.aulast=Mottonen+J%2C+Strand+A%2C+Symersky+J%2C+Sweet+RM%2C+Danley+DE%2C+Geoghegan+KF%2C+Gerard+RD%2C+Goldsmith+EJ&amp;rft.au=Mottonen+J%2C+Strand+A%2C+Symersky+J%2C+Sweet+RM%2C+Danley+DE%2C+Geoghegan+KF%2C+Gerard+RD%2C+Goldsmith+EJ&amp;rft.date=1992&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1038%2F355270a0&amp;rft_id=info%3Apmid%2F1731226&amp;rft.issue=6357&amp;rft.jtitle=Nature&amp;rft.pages=270-273&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=355" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-50"><span class="mw-cite-backlink"><b><a href="#cite_ref-50">^</a></b></span> <span class="reference-text"><span class="citation journal">Chang WS, Harper PL (1997). "Commercial antithrombin concentrate contains inactive L-forms of antithrombin". <i>Thromb. Haemost.</i> <b>77</b> (2): 323–328. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/9157590">9157590</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAntithrombin&amp;rft.atitle=Commercial+antithrombin+concentrate+contains+inactive+L-forms+of+antithrombin&amp;rft.au=Chang+WS%2C+Harper+PL&amp;rft.aulast=Chang+WS%2C+Harper+PL&amp;rft.date=1997&amp;rft.genre=article&amp;rft_id=info%3Apmid%2F9157590&amp;rft.issue=2&amp;rft.jtitle=Thromb.+Haemost.&amp;rft.pages=323-328&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=77" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-51"><span class="mw-cite-backlink"><b><a href="#cite_ref-51">^</a></b></span> <span class="reference-text"><span class="citation journal">Wardell MR, Chang WS, Bruce D, Skinner R, Lesk AM, Carrell RW (1997). "Preparative induction and characterization of L-antithrombin: a structural homologue of latent plasminogen activator inhibitor-1". <i>Biochemistry</i> <b>36</b> (42): 13133–13142. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1021%2Fbi970664u">10.1021/bi970664u</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/9335576">9335576</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAntithrombin&amp;rft.atitle=Preparative+induction+and+characterization+of+L-antithrombin%3A+a+structural+homologue+of+latent+plasminogen+activator+inhibitor-1&amp;rft.aulast=Wardell+MR%2C+Chang+WS%2C+Bruce+D%2C+Skinner+R%2C+Lesk+AM%2C+Carrell+RW&amp;rft.au=Wardell+MR%2C+Chang+WS%2C+Bruce+D%2C+Skinner+R%2C+Lesk+AM%2C+Carrell+RW&amp;rft.date=1997&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1021%2Fbi970664u&amp;rft_id=info%3Apmid%2F9335576&amp;rft.issue=42&amp;rft.jtitle=Biochemistry&amp;rft.pages=13133-13142&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=36" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-52"><span class="mw-cite-backlink"><b><a href="#cite_ref-52">^</a></b></span> <span class="reference-text"><span class="citation journal">Carrell RW, Huntington JA, Mushunje A, Zhou A (2001). "The conformational basis of thrombosis". <i>Thromb. Haemost.</i> <b>86</b> (1): 14–22. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/11487000">11487000</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAntithrombin&amp;rft.atitle=The+conformational+basis+of+thrombosis&amp;rft.au=Carrell+RW%2C+Huntington+JA%2C+Mushunje+A%2C+Zhou+A&amp;rft.aulast=Carrell+RW%2C+Huntington+JA%2C+Mushunje+A%2C+Zhou+A&amp;rft.date=2001&amp;rft.genre=article&amp;rft_id=info%3Apmid%2F11487000&amp;rft.issue=1&amp;rft.jtitle=Thromb.+Haemost.&amp;rft.pages=14-22&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=86" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-Zhou-53"><span class="mw-cite-backlink">^ <a href="#cite_ref-Zhou_53-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Zhou_53-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-Zhou_53-2"><sup><i><b>c</b></i></sup></a></span> <span class="reference-text"><span class="citation journal">Zhou A, Huntington JA, Carrell RW (1999). "Formation of the antithrombin heterodimer in vivo and the onset of thrombosis". <i>Blood</i> <b>94</b> (10): 3388–3396. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/10552948">10552948</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAntithrombin&amp;rft.atitle=Formation+of+the+antithrombin+heterodimer+in+vivo+and+the+onset+of+thrombosis&amp;rft.aulast=Zhou+A%2C+Huntington+JA%2C+Carrell+RW&amp;rft.au=Zhou+A%2C+Huntington+JA%2C+Carrell+RW&amp;rft.date=1999&amp;rft.genre=article&amp;rft_id=info%3Apmid%2F10552948&amp;rft.issue=10&amp;rft.jtitle=Blood&amp;rft.pages=3388-3396&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=94" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-54"><span class="mw-cite-backlink"><b><a href="#cite_ref-54">^</a></b></span> <span class="reference-text"><span class="citation journal">Larsson H, Akerud P, Nordling K, Raub-Segall E, Claesson-Welsh L, Björk I (2001). "A novel anti-angiogenic form of antithrombin with retained proteinase binding ability and heparin affinity". <i>J. Biol. Chem.</i> <b>276</b> (15): 11996–12002. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1074%2Fjbc.M010170200">10.1074/jbc.M010170200</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/11278631">11278631</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAntithrombin&amp;rft.atitle=A+novel+anti-angiogenic+form+of+antithrombin+with+retained+proteinase+binding+ability+and+heparin+affinity&amp;rft.au=Larsson+H%2C+Akerud+P%2C+Nordling+K%2C+Raub-Segall+E%2C+Claesson-Welsh+L%2C+Bj%C3%B6rk+I&amp;rft.aulast=Larsson+H%2C+Akerud+P%2C+Nordling+K%2C+Raub-Segall+E%2C+Claesson-Welsh+L%2C+Bj%C3%B6rk+I&amp;rft.date=2001&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1074%2Fjbc.M010170200&amp;rft_id=info%3Apmid%2F11278631&amp;rft.issue=15&amp;rft.jtitle=J.+Biol.+Chem.&amp;rft.pages=11996-12002&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=276" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-55"><span class="mw-cite-backlink"><b><a href="#cite_ref-55">^</a></b></span> <span class="reference-text"><span class="citation journal">O'Reilly MS (2007). "Antiangiogenic antithrombin". <i>Semin. Thromb. Hemost.</i> <b>33</b> (7): 660–666. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1055%2Fs-2007-991533">10.1055/s-2007-991533</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/18000792">18000792</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAntithrombin&amp;rft.atitle=Antiangiogenic+antithrombin&amp;rft.aulast=O%27Reilly+MS&amp;rft.au=O%27Reilly+MS&amp;rft.date=2007&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1055%2Fs-2007-991533&amp;rft_id=info%3Apmid%2F18000792&amp;rft.issue=7&amp;rft.jtitle=Semin.+Thromb.+Hemost.&amp;rft.pages=660-666&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=33" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-56"><span class="mw-cite-backlink"><b><a href="#cite_ref-56">^</a></b></span> <span class="reference-text"><span class="citation journal">O'Reilly MS, Pirie-Shepherd S, Lane WS, Folkman J (1999). "Antiangiogenic activity of the cleaved conformation of the serpin antithrombin". <i>Science</i> <b>285</b> (5435): 1926–1928. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1126%2Fscience.285.5435.1926">10.1126/science.285.5435.1926</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/10489375">10489375</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAntithrombin&amp;rft.atitle=Antiangiogenic+activity+of+the+cleaved+conformation+of+the+serpin+antithrombin&amp;rft.aulast=O%27Reilly+MS%2C+Pirie-Shepherd+S%2C+Lane+WS%2C+Folkman+J&amp;rft.au=O%27Reilly+MS%2C+Pirie-Shepherd+S%2C+Lane+WS%2C+Folkman+J&amp;rft.date=1999&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1126%2Fscience.285.5435.1926&amp;rft_id=info%3Apmid%2F10489375&amp;rft.issue=5435&amp;rft.jtitle=Science&amp;rft.pages=1926-1928&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=285" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
</ol>
</div>
<h2><span class="mw-headline" id="Further_reading">Further reading</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Antithrombin&amp;action=edit&amp;section=18" title="Edit section: Further reading">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<ul>
<li><span class="citation thesis">Panzer-Heinig, Sabine (2009). <a rel="nofollow" class="external text" href="http://www.diss.fu-berlin.de/diss/receive/FUDISS_thesis_000000011534"><i>Antithrombin (III) - Establishing Pediatric Reference Values, Relevance for DIC 1992 versus 2007</i></a> (Thesis). Medizinische Fakultät Charité - Universitätsmedizin Berlin.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAntithrombin&amp;rft.aulast=Panzer-Heinig%2C+Sabine&amp;rft.au=Panzer-Heinig%2C+Sabine&amp;rft.btitle=Antithrombin+%28III%29+-+Establishing+Pediatric+Reference+Values%2C+Relevance+for+DIC+1992+versus+2007&amp;rft.date=2009&amp;rft.genre=book&amp;rft_id=http%3A%2F%2Fwww.diss.fu-berlin.de%2Fdiss%2Freceive%2FFUDISS_thesis_000000011534&amp;rft.pub=Medizinische+Fakult%C3%A4t+Charit%C3%A9+-+Universit%C3%A4tsmedizin+Berlin&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook" class="Z3988"><span style="display:none;">&#160;</span></span></li>
</ul>
<h2><span class="mw-headline" id="External_links">External links</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Antithrombin&amp;action=edit&amp;section=19" title="Edit section: External links">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<ul>
<li>The <a href="/wiki/MEROPS" title="MEROPS">MEROPS</a> online database for peptidases and their inhibitors: <a rel="nofollow" class="external text" href="http://merops.sanger.ac.uk/cgi-bin/merops.cgi?id=I04.018">I04.018</a></li>
<li><a rel="nofollow" class="external text" href="//www.nlm.nih.gov/cgi/mesh/2011/MB_cgi?mode=&amp;term=Antithrombin+III">Antithrombin III</a> at the US National Library of Medicine <a href="/wiki/Medical_Subject_Headings" title="Medical Subject Headings">Medical Subject Headings</a> (MeSH)</li>
</ul>
<table class="navbox" style="border-spacing:0">
<tr>
<td style="padding:2px">
<table class="nowraplinks collapsible autocollapse navbox-inner" style="border-spacing:0;background:transparent;color:inherit">
<tr>
<th scope="col" class="navbox-title" colspan="2">
<div class="plainlinks hlist navbar mini">
<ul>
<li class="nv-view"><a href="/wiki/Template:Coagulation" title="Template:Coagulation"><span title="View this template" style=";;background:none transparent;border:none;">v</span></a></li>
<li class="nv-talk"><a href="/wiki/Template_talk:Coagulation" title="Template talk:Coagulation"><span title="Discuss this template" style=";;background:none transparent;border:none;">t</span></a></li>
<li class="nv-edit"><a class="external text" href="//en.wikipedia.org/w/index.php?title=Template:Coagulation&amp;action=edit"><span title="Edit this template" style=";;background:none transparent;border:none;">e</span></a></li>
</ul>
</div>
<div style="font-size:110%"><a href="/wiki/Protein" title="Protein">Proteins</a>: <a href="/wiki/Coagulation" title="Coagulation">coagulation</a></div>
</th>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group"><a href="/wiki/Coagulation" title="Coagulation">Coagulation&#160;factors</a></th>
<td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em"></div>
<table class="nowraplinks navbox-subgroup" style="border-spacing:0">
<tr>
<th scope="row" class="navbox-group"><a href="/wiki/Coagulation#Platelet_activation" title="Coagulation">Primary hemostasis</a></th>
<td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Von_Willebrand_factor" title="Von Willebrand factor">vWF</a></li>
<li><i><a href="/wiki/Platelet_membrane_glycoprotein" title="Platelet membrane glycoprotein">platelet membrane glycoproteins</a>:</i> <a href="/wiki/Glycoprotein_Ib" title="Glycoprotein Ib">Ib</a> (<a href="/wiki/GP1BA" title="GP1BA">A</a></li>
<li><a href="/wiki/GP1BB" title="GP1BB">B</a></li>
<li><a href="/wiki/Glycoprotein_IX" title="Glycoprotein IX">IX</a>)</li>
<li><a href="/wiki/Glycoprotein_IIb/IIIa" title="Glycoprotein IIb/IIIa">IIb/IIIa</a> (<a href="/wiki/ITGA2B" title="ITGA2B">IIb</a></li>
<li><a href="/wiki/CD61" title="CD61">IIIa</a>)</li>
<li><a href="/wiki/GPVI" title="GPVI">VI</a></li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group"><a href="/wiki/Coagulation#Contact_activation_pathway_.28intrinsic.29" title="Coagulation">Intrinsic pathway</a></th>
<td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/High-molecular-weight_kininogen" title="High-molecular-weight kininogen">HMWK</a>/<a href="/wiki/Bradykinin" title="Bradykinin">Bradykinin</a></li>
<li><a href="/wiki/Prekallikrein" title="Prekallikrein">Prekallikrein</a>/<a href="/wiki/Kallikrein" title="Kallikrein">Kallikrein</a></li>
<li><a href="/wiki/Factor_XII" title="Factor XII">XII "Hageman"</a></li>
<li><a href="/wiki/Factor_XI" title="Factor XI">XI</a></li>
<li><a href="/wiki/Factor_IX" title="Factor IX">IX</a></li>
<li><a href="/wiki/Factor_VIII" title="Factor VIII">VIII</a></li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group"><a href="/wiki/Coagulation#Tissue_factor_pathway_.28extrinsic.29" title="Coagulation">Extrinsic pathway</a></th>
<td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Tissue_factor" title="Tissue factor">III "Tissue factor"</a></li>
<li><a href="/wiki/Factor_VII" title="Factor VII">VII</a></li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group"><a href="/wiki/Coagulation#Final_common_pathway" title="Coagulation">Common pathway</a></th>
<td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Factor_X" title="Factor X">X</a></li>
<li><a href="/wiki/Factor_V" title="Factor V">V</a></li>
<li><a href="/wiki/Thrombin" title="Thrombin">II "(Pro)thrombin"</a></li>
<li><a href="/wiki/Fibrin" title="Fibrin">I "Fibrin"</a></li>
<li><a href="/wiki/Fibrinogen" title="Fibrinogen">Fibrinogen</a> (<a href="/wiki/Fibrinogen_alpha_chain" title="Fibrinogen alpha chain">FGA</a>, <a href="/wiki/FGG" title="FGG">FGG</a>)</li>
<li><a href="/wiki/Factor_XIII" title="Factor XIII">XIII</a></li>
</ul>
</div>
</td>
</tr>
</table>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group"><a href="/wiki/Anticoagulant" title="Anticoagulant">Coagulation inhibitors</a></th>
<td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><strong class="selflink">Antithrombin (inhibits II, IX, X, XI, XII)</strong></li>
<li><a href="/wiki/Protein_C" title="Protein C">Protein C (inhibits V, VIII)</a>/<a href="/wiki/Protein_S" title="Protein S">Protein S (cofactor for protein C)</a></li>
<li><a href="/wiki/Protein_Z" title="Protein Z">Protein Z (inhibits X)</a></li>
<li><a href="/wiki/Protein_Z-related_protease_inhibitor" title="Protein Z-related protease inhibitor">ZPI (inhibits X, XI)</a></li>
<li><a href="/wiki/Tissue_factor_pathway_inhibitor" title="Tissue factor pathway inhibitor">TFPI (inhibits III)</a></li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group"><a href="/wiki/Thrombolysis" title="Thrombolysis">Thrombolysis</a>/<a href="/wiki/Fibrinolysis" title="Fibrinolysis">fibrinolysis</a></th>
<td class="navbox-list navbox-even hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Plasmin" title="Plasmin">Plasmin</a></li>
<li><a href="/wiki/Tissue_plasminogen_activator" title="Tissue plasminogen activator">tPA</a>/<a href="/wiki/Urokinase" title="Urokinase">urokinase</a></li>
<li><a href="/wiki/Plasminogen_activator_inhibitor-1" title="Plasminogen activator inhibitor-1">PAI-1</a>/<a href="/wiki/Plasminogen_activator_inhibitor-2" title="Plasminogen activator inhibitor-2">2</a></li>
<li><a href="/wiki/Alpha_2-antiplasmin" title="Alpha 2-antiplasmin">α2-AP</a></li>
<li><a href="/wiki/Alpha-2-Macroglobulin" title="Alpha-2-Macroglobulin">α2-macroglobulin</a></li>
<li><a href="/wiki/Carboxypeptidase_B2" title="Carboxypeptidase B2">TAFI</a></li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<td class="navbox-abovebelow" colspan="2" style="background: transparent; padding: 0px;">
<table class="nowraplinks navbox-subgroup" style="border-spacing:0">
<tr>
<th scope="col" class="navbox-title" colspan="2">
<div class="plainlinks hlist navbar mini">
<ul>
<li class="nv-view"><a href="/wiki/Template:Myeloid_navs" title="Template:Myeloid navs"><span title="View this template" style=";;background:none transparent;border:none;">v</span></a></li>
<li class="nv-talk"><a href="/wiki/Template_talk:Myeloid_navs" title="Template talk:Myeloid navs"><span title="Discuss this template" style=";;background:none transparent;border:none;">t</span></a></li>
<li class="nv-edit"><a class="external text" href="//en.wikipedia.org/w/index.php?title=Template:Myeloid_navs&amp;action=edit"><span title="Edit this template" style=";;background:none transparent;border:none;">e</span></a></li>
</ul>
</div>
<div style="font-size:110%">Index of <a href="/wiki/Myeloid" title="Myeloid">cells from bone marrow</a></div>
</th>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group">Description</th>
<td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Template:Myeloid_innate_immune_system" title="Template:Myeloid innate immune system">Immune system</a></li>
<li><a href="/wiki/Template:Myeloid_blood_cells_and_plasma" title="Template:Myeloid blood cells and plasma">Cells</a></li>
<li><a href="/wiki/Template:Myeloid_physiology" title="Template:Myeloid physiology">Physiology</a>
<ul>
<li><a href="/wiki/Template:Coagulation" title="Template:Coagulation">coagulation</a></li>
<li><a href="/wiki/Template:Hemeproteins" title="Template:Hemeproteins">proteins</a></li>
<li><a href="/wiki/Template:Granule_contents" title="Template:Granule contents">granule contents</a></li>
<li><a href="/wiki/Template:Colony-stimulating_factors" title="Template:Colony-stimulating factors">colony-stimulating</a></li>
<li>heme and porphyrin
<ul>
<li><i><a href="/wiki/Template:Porphyrin_metabolism_enzymes" title="Template:Porphyrin metabolism enzymes">metabolism</a></i></li>
<li><i><a href="/wiki/Template:Heme_metabolism_intermediates" title="Template:Heme metabolism intermediates">intermediates</a></i></li>
</ul>
</li>
</ul>
</li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group">Disease</th>
<td class="navbox-list navbox-even hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Template:Diseases_of_RBCs_and_megakaryocytes" title="Template:Diseases of RBCs and megakaryocytes">Red blood cell</a></li>
<li><a href="/wiki/Template:Monocyte_and_granulocyte_disease" title="Template:Monocyte and granulocyte disease">Monocyte and granulocyte</a></li>
<li><a href="/wiki/Template:Myeloid_malignancy" title="Template:Myeloid malignancy">Neoplasms and cancer</a></li>
<li><a href="/wiki/Template:Histiocytosis" title="Template:Histiocytosis">Histiocytosis</a></li>
<li><a href="/wiki/Template:Cardiovascular_system_symptoms_and_signs" title="Template:Cardiovascular system symptoms and signs">Symptoms and signs</a>
<ul>
<li><a href="/wiki/Template:Eponymous_medical_signs_for_hematology" title="Template:Eponymous medical signs for hematology">eponymous</a></li>
</ul>
</li>
<li><a href="/wiki/Template:Myeloid_blood_tests" title="Template:Myeloid blood tests">Blood tests</a>
<ul>
<li><a href="/wiki/Template:Abnormal_clinical_and_laboratory_findings_for_blood" title="Template:Abnormal clinical and laboratory findings for blood">findings</a></li>
</ul>
</li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group">Treatment</th>
<td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Template:Transfusion_medicine" title="Template:Transfusion medicine">Transfusion</a></li>
<li>Drugs
<ul>
<li><a href="/wiki/Template:Antithrombotics" title="Template:Antithrombotics">thrombosis</a></li>
<li><a href="/wiki/Template:Antihemorrhagics" title="Template:Antihemorrhagics">bleeding</a></li>
<li><a href="/wiki/Template:B03,_B05,_B06" title="Template:B03, B05, B06">other</a></li>
</ul>
</li>
</ul>
</div>
</td>
</tr>
</table>
</td>
</tr>
</table>
</td>
</tr>
</table>
<table class="navbox" style="border-spacing:0">
<tr>
<td style="padding:2px">
<table class="nowraplinks collapsible autocollapse navbox-inner" style="border-spacing:0;background:transparent;color:inherit">
<tr>
<th scope="col" class="navbox-title" colspan="2" style="background:#e7dcc3">
<div class="plainlinks hlist navbar mini">
<ul>
<li class="nv-view"><a href="/wiki/Template:Serpins" title="Template:Serpins"><span title="View this template" style=";background:#e7dcc3;background:none transparent;border:none;">v</span></a></li>
<li class="nv-talk"><a href="/w/index.php?title=Template_talk:Serpins&amp;action=edit&amp;redlink=1" class="new" title="Template talk:Serpins (page does not exist)"><span title="Discuss this template" style=";background:#e7dcc3;background:none transparent;border:none;">t</span></a></li>
<li class="nv-edit"><a class="external text" href="//en.wikipedia.org/w/index.php?title=Template:Serpins&amp;action=edit"><span title="Edit this template" style=";background:#e7dcc3;background:none transparent;border:none;">e</span></a></li>
</ul>
</div>
<div style="font-size:110%"><a href="/wiki/Serpin" title="Serpin">Serpins</a></div>
</th>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group" style="background-color: AntiqueWhite">inhibitory</th>
<td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Alpha_1-antichymotrypsin" title="Alpha 1-antichymotrypsin">Alpha 1-antichymotrypsin</a></li>
<li><a href="/wiki/Alpha_1-antitrypsin" title="Alpha 1-antitrypsin" class="mw-redirect">Alpha 1-antitrypsin</a></li>
<li><a href="/wiki/Alpha_2-antiplasmin" title="Alpha 2-antiplasmin">Alpha 2-antiplasmin</a></li>
<li><strong class="selflink">Antithrombin</strong></li>
<li><a href="/wiki/C1-inhibitor" title="C1-inhibitor">C1-inhibitor</a></li>
<li><a href="/wiki/Heparin_cofactor_II" title="Heparin cofactor II">Heparin cofactor II</a></li>
<li><a href="/wiki/Protein_C_inhibitor" title="Protein C inhibitor">Protein C inhibitor</a></li>
<li><a href="/wiki/Plasminogen_activator_inhibitor-1" title="Plasminogen activator inhibitor-1">Plasminogen activator inhibitor-1</a></li>
<li><a href="/wiki/Plasminogen_activator_inhibitor-2" title="Plasminogen activator inhibitor-2">Plasminogen activator inhibitor-2</a></li>
<li><a href="/wiki/Protein_Z-related_protease_inhibitor" title="Protein Z-related protease inhibitor">Protein Z-related protease inhibitor</a></li>
</ul>
<ul>
<li><a href="/wiki/Alpha_1-antitrypsin" title="Alpha 1-antitrypsin" class="mw-redirect">SERPINA1</a></li>
<li><a href="/wiki/SERPINA2" title="SERPINA2">SERPINA2</a></li>
<li><a href="/wiki/Alpha_1-antichymotrypsin" title="Alpha 1-antichymotrypsin">SERPINA3</a></li>
<li><a href="/wiki/SERPINA4" title="SERPINA4">SERPINA4</a></li>
<li><a href="/wiki/SERPINA5" title="SERPINA5" class="mw-redirect">SERPINA5</a></li>
<li><a href="/wiki/SERPINA6" title="SERPINA6" class="mw-redirect">SERPINA6</a></li>
<li><a href="/wiki/Thyroxine-binding_globulin" title="Thyroxine-binding globulin">SERPINA7</a></li>
<li><a href="/wiki/Angiotensin" title="Angiotensin">SERPINA8</a></li>
<li><a href="/wiki/SERPINA9" title="SERPINA9">SERPINA9</a></li>
<li><a href="/wiki/Uterine_serpin" title="Uterine serpin">SERPINA14</a></li>
</ul>
<ul>
<li><a href="/wiki/SERPINB1" title="SERPINB1">SERPINB1</a></li>
<li><a href="/wiki/Plasminogen_activator_inhibitor-2" title="Plasminogen activator inhibitor-2">SERPINB2</a></li>
<li><a href="/wiki/SERPINB3" title="SERPINB3">SERPINB3</a></li>
<li><a href="/wiki/SERPINB4" title="SERPINB4">SERPINB4</a></li>
<li><a href="/wiki/Maspin" title="Maspin">SERPINB5</a></li>
<li><a href="/wiki/SERPINB6" title="SERPINB6">SERPINB6</a></li>
<li><a href="/wiki/SERPINB7" title="SERPINB7">SERPINB7</a></li>
<li><a href="/wiki/SERPINB8" title="SERPINB8">SERPINB8</a></li>
<li><a href="/wiki/SERPINB9" title="SERPINB9">SERPINB9</a></li>
<li><a href="/wiki/SERPINB13" title="SERPINB13">SERPINB13</a></li>
</ul>
<ul>
<li><strong class="selflink">SERPINC1</strong></li>
<li><a href="/wiki/Heparin_cofactor_II" title="Heparin cofactor II">SERPIND1</a></li>
<li><a href="/wiki/Plasminogen_activator_inhibitor-1" title="Plasminogen activator inhibitor-1">SERPINE1</a></li>
<li><a href="/wiki/SERPINE2" title="SERPINE2">SERPINE2</a></li>
<li><a href="/wiki/SERPINE2" title="SERPINE2">SERPINE2</a></li>
<li><a href="/wiki/SERPINF1" title="SERPINF1" class="mw-redirect">SERPINF1</a></li>
<li><a href="/wiki/C1-inhibitor" title="C1-inhibitor">SERPING1</a></li>
<li><a href="/wiki/Heat_shock_protein_47" title="Heat shock protein 47">SERPINH1</a></li>
<li><a href="/wiki/SERPINI1" title="SERPINI1">SERPINI1</a></li>
<li><a href="/wiki/SERPINI2" title="SERPINI2">SERPINI2</a></li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group" style="background-color: AntiqueWhite"><a href="/wiki/Serpin#Cross_class_inhibitors" title="Serpin">Cross class inhibitory</a></th>
<td class="navbox-list navbox-even hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Myeloid_and_erythroid_nuclear_termination_stage-specific_protein" title="Myeloid and erythroid nuclear termination stage-specific protein">MENT</a></li>
<li><a href="/wiki/Squamous_cell_carcinoma_antigen-1" title="Squamous cell carcinoma antigen-1" class="mw-redirect">SCCA-1</a></li>
<li><a href="/w/index.php?title=CrmA&amp;action=edit&amp;redlink=1" class="new" title="CrmA (page does not exist)">crmA</a></li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group" style="background-color: AntiqueWhite">noninhibitory</th>
<td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Heat_shock_protein_47" title="Heat shock protein 47">Heat shock protein 47</a></li>
<li><a href="/wiki/Maspin" title="Maspin">Maspin</a></li>
<li><a href="/wiki/Ovalbumin" title="Ovalbumin">Ovalbumin</a></li>
<li><a href="/wiki/SERPINF1" title="SERPINF1" class="mw-redirect">SERPINF1</a></li>
<li><a href="/wiki/Thyroxine-binding_globulin" title="Thyroxine-binding globulin">Thyroxine-binding globulin</a></li>
<li><a href="/wiki/Transcortin" title="Transcortin">Transcortin</a></li>
<li><a href="/wiki/SERPINF1" title="SERPINF1" class="mw-redirect">SERPINF1</a></li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<td class="navbox-abovebelow" colspan="2" style="background-color: AntiqueWhite">
<div><i>see also <a href="/wiki/Template:Disorders_of_globin_and_globulin_proteins" title="Template:Disorders of globin and globulin proteins">disorders of globin and globulin proteins</a></i></div>
</td>
</tr>
</table>
</td>
</tr>
</table>
<table class="navbox" style="border-spacing:0">
<tr>
<td style="padding:2px">
<table class="nowraplinks collapsible autocollapse navbox-inner" style="border-spacing:0;background:transparent;color:inherit">
<tr>
<th scope="col" class="navbox-title" colspan="2" style="background:#e7dcc3">
<div class="plainlinks hlist navbar mini">
<ul>
<li class="nv-view"><a href="/wiki/Template:Globular_proteins" title="Template:Globular proteins"><span title="View this template" style=";background:#e7dcc3;background:none transparent;border:none;">v</span></a></li>
<li class="nv-talk"><a href="/wiki/Template_talk:Globular_proteins" title="Template talk:Globular proteins"><span title="Discuss this template" style=";background:#e7dcc3;background:none transparent;border:none;">t</span></a></li>
<li class="nv-edit"><a class="external text" href="//en.wikipedia.org/w/index.php?title=Template:Globular_proteins&amp;action=edit"><span title="Edit this template" style=";background:#e7dcc3;background:none transparent;border:none;">e</span></a></li>
</ul>
</div>
<div style="font-size:110%"><a href="/wiki/Protein" title="Protein">Proteins</a>: <a href="/wiki/Globular_protein" title="Globular protein">Globular proteins</a></div>
</th>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group" style="background-color: AntiqueWhite"><a href="/wiki/Blood_plasma" title="Blood plasma">Serum</a> <a href="/wiki/Globulin" title="Globulin">globulins</a></th>
<td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em"></div>
<table class="nowraplinks navbox-subgroup" style="border-spacing:0">
<tr>
<th scope="row" class="navbox-group" style="padding-left:0;padding-right:0;background-color: AntiqueWhite">
<div style="padding:0em 0.75em;"><a href="/wiki/Alpha_globulin" title="Alpha globulin">Alpha globulins</a></div>
</th>
<td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em"></div>
<table class="nowraplinks navbox-subgroup" style="border-spacing:0">
<tr>
<th scope="row" class="navbox-group" style="padding-left:0;padding-right:0;background-color: AntiqueWhite">
<div style="padding:0em 0.75em;"><span style="font-weight:normal;"><a href="/wiki/Serpin" title="Serpin">serpins</a>:</span></div>
</th>
<td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Alpha_globulin#Alpha_1_globulins" title="Alpha globulin">alpha-1</a> (<a href="/wiki/Alpha_1-antichymotrypsin" title="Alpha 1-antichymotrypsin">Alpha 1-antichymotrypsin</a>, <a href="/wiki/Alpha_1-antitrypsin" title="Alpha 1-antitrypsin" class="mw-redirect">Alpha 1-antitrypsin</a>)</li>
<li><a href="/wiki/Alpha_globulin#Alpha_2_globulins" title="Alpha globulin">alpha-2</a> (<a href="/wiki/Alpha_2-antiplasmin" title="Alpha 2-antiplasmin">Alpha 2-antiplasmin</a>)</li>
<li><strong class="selflink">Antithrombin</strong> (<a href="/wiki/Heparin_cofactor_II" title="Heparin cofactor II">Heparin cofactor II</a>)</li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group" style="padding-left:0;padding-right:0;background-color: AntiqueWhite">
<div style="padding:0em 0.75em;"><span style="font-weight:normal;"><a href="/wiki/Carrier_protein" title="Carrier protein">carrier proteins</a>:</span></div>
</th>
<td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li>alpha-1 (<a href="/wiki/Transcortin" title="Transcortin">Transcortin</a>)</li>
<li>alpha-2 (<a href="/wiki/Ceruloplasmin" title="Ceruloplasmin">Ceruloplasmin</a>)</li>
<li><a href="/wiki/Retinol_binding_protein" title="Retinol binding protein">Retinol binding protein</a></li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group" style="padding-left:0;padding-right:0;background-color: AntiqueWhite">
<div style="padding:0em 0.75em;"><span style="font-weight:normal;">other:</span></div>
</th>
<td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li>alpha-1 (<a href="/wiki/Orosomucoid" title="Orosomucoid">Orosomucoid</a>)</li>
<li>alpha-2 (<a href="/wiki/Alpha-2-Macroglobulin" title="Alpha-2-Macroglobulin">alpha-2-Macroglobulin</a>, <a href="/wiki/Haptoglobin" title="Haptoglobin">Haptoglobin</a>)</li>
</ul>
</div>
</td>
</tr>
</table>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group" style="padding-left:0;padding-right:0;background-color: AntiqueWhite">
<div style="padding:0em 0.75em;"><a href="/wiki/Beta_globulins" title="Beta globulins">Beta globulins</a></div>
</th>
<td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em"></div>
<table class="nowraplinks navbox-subgroup" style="border-spacing:0">
<tr>
<th scope="row" class="navbox-group" style="padding-left:0;padding-right:0;background-color: AntiqueWhite">
<div style="padding:0em 0.75em;"><span style="font-weight:normal;"><a href="/wiki/Carrier_protein" title="Carrier protein">carrier proteins</a>:</span></div>
</th>
<td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Sex_hormone-binding_globulin" title="Sex hormone-binding globulin">Sex hormone-binding globulin</a></li>
<li><a href="/wiki/Transferrin" title="Transferrin">Transferrin</a><br /></li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group" style="padding-left:0;padding-right:0;background-color: AntiqueWhite">
<div style="padding:0em 0.75em;"><span style="font-weight:normal;">other:</span></div>
</th>
<td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Angiostatin" title="Angiostatin">Angiostatin</a></li>
<li><a href="/wiki/Hemopexin" title="Hemopexin">Hemopexin</a></li>
<li><a href="/wiki/Beta-2_microglobulin" title="Beta-2 microglobulin">Beta-2 microglobulin</a></li>
<li><a href="/wiki/Factor_H" title="Factor H">Factor H</a></li>
<li><a href="/wiki/Plasmin" title="Plasmin">Plasminogen</a></li>
<li><a href="/wiki/Properdin" title="Properdin">Properdin</a></li>
</ul>
</div>
</td>
</tr>
</table>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group" style="padding-left:0;padding-right:0;background-color: AntiqueWhite">
<div style="padding:0em 0.75em;"><a href="/wiki/Gamma_globulin" title="Gamma globulin">Gamma globulin</a></div>
</th>
<td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Antibody" title="Antibody">Immunoglobulins</a></li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group" style="padding-left:0;padding-right:0;background-color: AntiqueWhite">
<div style="padding:0em 0.75em;">Other</div>
</th>
<td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Fibronectin" title="Fibronectin">Fibronectin</a> (fFN: <a href="/wiki/Fetal_fibronectin" title="Fetal fibronectin">Fetal fibronectin</a>)</li>
<li><a href="/wiki/Macroglobulin" title="Macroglobulin">Macroglobulin</a>/<a href="/wiki/Microglobulin" title="Microglobulin">Microglobulin</a></li>
<li><a href="/wiki/Transcobalamin" title="Transcobalamin">Transcobalamin</a></li>
</ul>
</div>
</td>
</tr>
</table>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group" style="background-color: AntiqueWhite">Other globulins</th>
<td class="navbox-list navbox-even hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Beta-lactoglobulin" title="Beta-lactoglobulin">Beta-lactoglobulin</a>
<ul>
<li><a href="/wiki/Lactoferrin" title="Lactoferrin">Lactoferrin</a></li>
</ul>
</li>
<li><a href="/wiki/Thyroglobulin" title="Thyroglobulin">Thyroglobulin</a></li>
<li><a href="/wiki/Alpha-lactalbumin" title="Alpha-lactalbumin">Alpha-lactalbumin</a></li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group" style="background-color: AntiqueWhite"><a href="/wiki/Albumin" title="Albumin">Albumins</a></th>
<td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em"></div>
<table class="nowraplinks navbox-subgroup" style="border-spacing:0">
<tr>
<th scope="row" class="navbox-group" style="padding-left:0;padding-right:0;background-color: AntiqueWhite">
<div style="padding:0em 0.75em;"><a href="/wiki/Egg_white" title="Egg white">Egg white</a></div>
</th>
<td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Conalbumin" title="Conalbumin">Conalbumin</a></li>
<li><a href="/wiki/Ovalbumin" title="Ovalbumin">Ovalbumin</a></li>
<li><a href="/wiki/Avidin" title="Avidin">Avidin</a></li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group" style="padding-left:0;padding-right:0;background-color: AntiqueWhite">
<div style="padding:0em 0.75em;"><a href="/wiki/Serum_albumin" title="Serum albumin">Serum albumin</a></div>
</th>
<td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Human_serum_albumin" title="Human serum albumin">Human serum albumin</a></li>
<li><a href="/wiki/Bovine_serum_albumin" title="Bovine serum albumin">Bovine serum albumin</a></li>
<li><a href="/wiki/Transthyretin" title="Transthyretin">Prealbumin</a></li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group" style="padding-left:0;padding-right:0;background-color: AntiqueWhite">
<div style="padding:0em 0.75em;">Other</div>
</th>
<td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/C-reactive_protein" title="C-reactive protein">C-reactive protein</a></li>
<li><a href="/wiki/Lactalbumin" title="Lactalbumin">Lactalbumin</a> (<a href="/wiki/Alpha-lactalbumin" title="Alpha-lactalbumin">Alpha-lactalbumin</a>)</li>
<li><a href="/wiki/Parvalbumin" title="Parvalbumin">Parvalbumin</a></li>
<li><a href="/wiki/Ricin" title="Ricin">Ricin</a></li>
</ul>
</div>
</td>
</tr>
</table>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<td class="navbox-abovebelow" colspan="2" style="background-color: AntiqueWhite">
<div>
<div class="plainlist">
<ul>
<li><i>see also</i> <a href="/wiki/Template:Disorders_of_globin_and_globulin_proteins" title="Template:Disorders of globin and globulin proteins">disorders of globin and globulin proteins</a></li>
</ul>
</div>
<table class="nowraplinks navbox-subgroup" style="border-spacing:0">
<tr>
<th scope="col" class="navbox-title" colspan="2">
<div class="plainlinks hlist navbar mini">
<ul>
<li class="nv-view"><a href="/wiki/Template:Protein_classification_navs" title="Template:Protein classification navs"><span title="View this template" style=";;background:none transparent;border:none;">v</span></a></li>
<li class="nv-talk"><a href="/w/index.php?title=Template_talk:Protein_classification_navs&amp;action=edit&amp;redlink=1" class="new" title="Template talk:Protein classification navs (page does not exist)"><span title="Discuss this template" style=";;background:none transparent;border:none;">t</span></a></li>
<li class="nv-edit"><a class="external text" href="//en.wikipedia.org/w/index.php?title=Template:Protein_classification_navs&amp;action=edit"><span title="Edit this template" style=";;background:none transparent;border:none;">e</span></a></li>
</ul>
</div>
<div style="font-size:110%">Index of <a href="/wiki/Protein" title="Protein">proteins</a></div>
</th>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group">Description</th>
<td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Template:Protein_topics" title="Template:Protein topics">Proteins</a></li>
<li><a href="/wiki/Template:Membrane_proteins" title="Template:Membrane proteins" class="mw-redirect">Membrane</a></li>
<li><a href="/wiki/Template:Globular_proteins" title="Template:Globular proteins">Globular</a>
<ul>
<li><a href="/wiki/Template:Enzymes" title="Template:Enzymes">enzymes</a></li>
<li><a href="/wiki/Template:Carrier_proteins" title="Template:Carrier proteins">carrier</a></li>
</ul>
</li>
<li><a href="/wiki/Template:Antibodies" title="Template:Antibodies">Antibodies</a></li>
<li><a href="/wiki/Template:Fibrous_proteins" title="Template:Fibrous proteins">Fibrous</a></li>
</ul>
</div>
</td>
</tr>
</table>
</div>
</td>
</tr>
</table>
</td>
</tr>
</table>


<!-- 
NewPP limit report
Parsed by mw1009
CPU time usage: 1.158 seconds
Real time usage: 1.283 seconds
Preprocessor visited node count: 6102/1000000
Preprocessor generated node count: 0/1500000
Post‐expand include size: 289685/2097152 bytes
Template argument size: 18440/2097152 bytes
Highest expansion depth: 14/40
Expensive parser function count: 0/500
Lua time usage: 0.369/10.000 seconds
Lua memory usage: 3.2 MB/50 MB
-->

<!-- 
Transclusion expansion time report (%,ms,calls,template)
100.00% 1061.444      1 - -total
 38.73%  411.101      1 - Template:Reflist
 31.76%  337.155      1 - Template:PBB
 31.48%  334.102      1 - Template:PBB/462
 31.02%  329.267      1 - Template:GNF_Protein_box
 30.00%  318.443      1 - Template:Infobox3cols
 23.64%  250.879     51 - Template:Cite_journal
 21.53%  228.533     10 - Template:Navbox
 10.27%  108.990      1 - Template:Homologene2PDBe
  9.82%  104.193      1 - Template:Homologene2PDBe/part4
-->

<!-- Saved in parser cache with key enwiki:pcache:idhash:511049-0!*!0!!en!4!* and timestamp 20150709025901 and revision id 659794948
 -->
<noscript><img src="//en.wikipedia.org/wiki/Special:CentralAutoLogin/start?type=1x1" alt="" title="" width="1" height="1" style="border: none; position: absolute;" /></noscript></div>					<div class="printfooter">
						Retrieved from "<a dir="ltr" href="https://en.wikipedia.org/w/index.php?title=Antithrombin&amp;oldid=659794948">https://en.wikipedia.org/w/index.php?title=Antithrombin&amp;oldid=659794948</a>"					</div>
				<div id='catlinks' class='catlinks'><div id="mw-normal-catlinks" class="mw-normal-catlinks"><a href="/wiki/Help:Category" title="Help:Category">Categories</a>: <ul><li><a href="/wiki/Category:Human_proteins" title="Category:Human proteins">Human proteins</a></li><li><a href="/wiki/Category:Coagulation_system" title="Category:Coagulation system">Coagulation system</a></li><li><a href="/wiki/Category:Serine_protease_inhibitors" title="Category:Serine protease inhibitors">Serine protease inhibitors</a></li></ul></div><div id="mw-hidden-catlinks" class="mw-hidden-catlinks mw-hidden-cats-hidden">Hidden categories: <ul><li><a href="/wiki/Category:Articles_that_use_a_Medicine_navs_subtemplate" title="Category:Articles that use a Medicine navs subtemplate">Articles that use a Medicine navs subtemplate</a></li></ul></div></div>				<div class="visualClear"></div>
							</div>
		</div>
		<div id="mw-navigation">
			<h2>Navigation menu</h2>

			<div id="mw-head">
									<div id="p-personal" role="navigation" class="" aria-labelledby="p-personal-label">
						<h3 id="p-personal-label">Personal tools</h3>
						<ul>
							<li id="pt-createaccount"><a href="/w/index.php?title=Special:UserLogin&amp;returnto=Antithrombin&amp;type=signup" title="You are encouraged to create an account and log in; however, it is not mandatory">Create account</a></li><li id="pt-login"><a href="/w/index.php?title=Special:UserLogin&amp;returnto=Antithrombin" title="You're encouraged to log in; however, it's not mandatory. [o]" accesskey="o">Log in</a></li>						</ul>
					</div>
									<div id="left-navigation">
										<div id="p-namespaces" role="navigation" class="vectorTabs" aria-labelledby="p-namespaces-label">
						<h3 id="p-namespaces-label">Namespaces</h3>
						<ul>
															<li  id="ca-nstab-main" class="selected"><span><a href="/wiki/Antithrombin"  title="View the content page [c]" accesskey="c">Article</a></span></li>
															<li  id="ca-talk"><span><a href="/wiki/Talk:Antithrombin"  title="Discussion about the content page [t]" accesskey="t" rel="discussion">Talk</a></span></li>
													</ul>
					</div>
										<div id="p-variants" role="navigation" class="vectorMenu emptyPortlet" aria-labelledby="p-variants-label">
												<h3 id="p-variants-label">
							<span>Variants</span><a href="#"></a>
						</h3>

						<div class="menu">
							<ul>
															</ul>
						</div>
					</div>
									</div>
				<div id="right-navigation">
										<div id="p-views" role="navigation" class="vectorTabs" aria-labelledby="p-views-label">
						<h3 id="p-views-label">Views</h3>
						<ul>
															<li id="ca-view" class="selected"><span><a href="/wiki/Antithrombin" >Read</a></span></li>
															<li id="ca-edit"><span><a href="/w/index.php?title=Antithrombin&amp;action=edit"  title="Edit this page [e]" accesskey="e">Edit</a></span></li>
															<li id="ca-history" class="collapsible"><span><a href="/w/index.php?title=Antithrombin&amp;action=history"  title="Past versions of this page [h]" accesskey="h">View history</a></span></li>
													</ul>
					</div>
										<div id="p-cactions" role="navigation" class="vectorMenu emptyPortlet" aria-labelledby="p-cactions-label">
						<h3 id="p-cactions-label"><span>More</span><a href="#"></a></h3>

						<div class="menu">
							<ul>
															</ul>
						</div>
					</div>
										<div id="p-search" role="search">
						<h3>
							<label for="searchInput">Search</label>
						</h3>

						<form action="/w/index.php" id="searchform">
							<div id="simpleSearch">
							<input type="search" name="search" placeholder="Search" title="Search Wikipedia [f]" accesskey="f" id="searchInput" /><input type="hidden" value="Special:Search" name="title" /><input type="submit" name="fulltext" value="Search" title="Search Wikipedia for this text" id="mw-searchButton" class="searchButton mw-fallbackSearchButton" /><input type="submit" name="go" value="Go" title="Go to a page with this exact name if one exists" id="searchButton" class="searchButton" />							</div>
						</form>
					</div>
									</div>
			</div>
			<div id="mw-panel">
				<div id="p-logo" role="banner"><a class="mw-wiki-logo" href="/wiki/Main_Page"  title="Visit the main page"></a></div>
						<div class="portal" role="navigation" id='p-navigation' aria-labelledby='p-navigation-label'>
			<h3 id='p-navigation-label'>Navigation</h3>

			<div class="body">
									<ul>
						<li id="n-mainpage-description"><a href="/wiki/Main_Page" title="Visit the main page [z]" accesskey="z">Main page</a></li><li id="n-contents"><a href="/wiki/Portal:Contents" title="Guides to browsing Wikipedia">Contents</a></li><li id="n-featuredcontent"><a href="/wiki/Portal:Featured_content" title="Featured content – the best of Wikipedia">Featured content</a></li><li id="n-currentevents"><a href="/wiki/Portal:Current_events" title="Find background information on current events">Current events</a></li><li id="n-randompage"><a href="/wiki/Special:Random" title="Load a random article [x]" accesskey="x">Random article</a></li><li id="n-sitesupport"><a href="https://donate.wikimedia.org/wiki/Special:FundraiserRedirector?utm_source=donate&amp;utm_medium=sidebar&amp;utm_campaign=C13_en.wikipedia.org&amp;uselang=en" title="Support us">Donate to Wikipedia</a></li><li id="n-shoplink"><a href="//shop.wikimedia.org" title="Visit the Wikimedia Shop">Wikipedia store</a></li>					</ul>
							</div>
		</div>
			<div class="portal" role="navigation" id='p-interaction' aria-labelledby='p-interaction-label'>
			<h3 id='p-interaction-label'>Interaction</h3>

			<div class="body">
									<ul>
						<li id="n-help"><a href="/wiki/Help:Contents" title="Guidance on how to use and edit Wikipedia">Help</a></li><li id="n-aboutsite"><a href="/wiki/Wikipedia:About" title="Find out about Wikipedia">About Wikipedia</a></li><li id="n-portal"><a href="/wiki/Wikipedia:Community_portal" title="About the project, what you can do, where to find things">Community portal</a></li><li id="n-recentchanges"><a href="/wiki/Special:RecentChanges" title="A list of recent changes in the wiki [r]" accesskey="r">Recent changes</a></li><li id="n-contactpage"><a href="//en.wikipedia.org/wiki/Wikipedia:Contact_us">Contact page</a></li>					</ul>
							</div>
		</div>
			<div class="portal" role="navigation" id='p-tb' aria-labelledby='p-tb-label'>
			<h3 id='p-tb-label'>Tools</h3>

			<div class="body">
									<ul>
						<li id="t-whatlinkshere"><a href="/wiki/Special:WhatLinksHere/Antithrombin" title="List of all English Wikipedia pages containing links to this page [j]" accesskey="j">What links here</a></li><li id="t-recentchangeslinked"><a href="/wiki/Special:RecentChangesLinked/Antithrombin" title="Recent changes in pages linked from this page [k]" accesskey="k">Related changes</a></li><li id="t-upload"><a href="/wiki/Wikipedia:File_Upload_Wizard" title="Upload files [u]" accesskey="u">Upload file</a></li><li id="t-specialpages"><a href="/wiki/Special:SpecialPages" title="A list of all special pages [q]" accesskey="q">Special pages</a></li><li id="t-permalink"><a href="/w/index.php?title=Antithrombin&amp;oldid=659794948" title="Permanent link to this revision of the page">Permanent link</a></li><li id="t-info"><a href="/w/index.php?title=Antithrombin&amp;action=info" title="More information about this page">Page information</a></li><li id="t-wikibase"><a href="//www.wikidata.org/wiki/Q416336" title="Link to connected data repository item [g]" accesskey="g">Wikidata item</a></li><li id="t-cite"><a href="/w/index.php?title=Special:CiteThisPage&amp;page=Antithrombin&amp;id=659794948" title="Information on how to cite this page">Cite this page</a></li>					</ul>
							</div>
		</div>
			<div class="portal" role="navigation" id='p-coll-print_export' aria-labelledby='p-coll-print_export-label'>
			<h3 id='p-coll-print_export-label'>Print/export</h3>

			<div class="body">
									<ul>
						<li id="coll-create_a_book"><a href="/w/index.php?title=Special:Book&amp;bookcmd=book_creator&amp;referer=Antithrombin">Create a book</a></li><li id="coll-download-as-rdf2latex"><a href="/w/index.php?title=Special:Book&amp;bookcmd=render_article&amp;arttitle=Antithrombin&amp;oldid=659794948&amp;writer=rdf2latex">Download as PDF</a></li><li id="t-print"><a href="/w/index.php?title=Antithrombin&amp;printable=yes" title="Printable version of this page [p]" accesskey="p">Printable version</a></li>					</ul>
							</div>
		</div>
			<div class="portal" role="navigation" id='p-lang' aria-labelledby='p-lang-label'>
			<h3 id='p-lang-label'>Languages</h3>

			<div class="body">
									<ul>
						<li class="interlanguage-link interwiki-de"><a href="//de.wikipedia.org/wiki/Antithrombin_III" title="Antithrombin III – German" lang="de" hreflang="de">Deutsch</a></li><li class="interlanguage-link interwiki-es"><a href="//es.wikipedia.org/wiki/Antitrombina" title="Antitrombina – Spanish" lang="es" hreflang="es">Español</a></li><li class="interlanguage-link interwiki-fa"><a href="//fa.wikipedia.org/wiki/%D8%A2%D9%86%D8%AA%DB%8C%E2%80%8C%D8%AA%D8%B1%D9%88%D9%85%D8%A8%DB%8C%D9%86" title="آنتی‌ترومبین – Persian" lang="fa" hreflang="fa">فارسی</a></li><li class="interlanguage-link interwiki-fr"><a href="//fr.wikipedia.org/wiki/Antithrombine" title="Antithrombine – French" lang="fr" hreflang="fr">Français</a></li><li class="interlanguage-link interwiki-id"><a href="//id.wikipedia.org/wiki/Anti-trombin" title="Anti-trombin – Indonesian" lang="id" hreflang="id">Bahasa Indonesia</a></li><li class="interlanguage-link interwiki-it"><a href="//it.wikipedia.org/wiki/Antitrombina" title="Antitrombina – Italian" lang="it" hreflang="it">Italiano</a></li><li class="interlanguage-link interwiki-he"><a href="//he.wikipedia.org/wiki/%D7%90%D7%A0%D7%98%D7%99%D7%AA%D7%A8%D7%95%D7%9E%D7%91%D7%99%D7%9F" title="אנטיתרומבין – Hebrew" lang="he" hreflang="he">עברית</a></li><li class="interlanguage-link interwiki-nl"><a href="//nl.wikipedia.org/wiki/Antitrombine" title="Antitrombine – Dutch" lang="nl" hreflang="nl">Nederlands</a></li><li class="interlanguage-link interwiki-pl"><a href="//pl.wikipedia.org/wiki/Antytrombina" title="Antytrombina – Polish" lang="pl" hreflang="pl">Polski</a></li><li class="interlanguage-link interwiki-pt"><a href="//pt.wikipedia.org/wiki/Antitrombina" title="Antitrombina – Portuguese" lang="pt" hreflang="pt">Português</a></li><li class="interlanguage-link interwiki-ru"><a href="//ru.wikipedia.org/wiki/%D0%90%D0%BD%D1%82%D0%B8%D1%82%D1%80%D0%BE%D0%BC%D0%B1%D0%B8%D0%BD" title="Антитромбин – Russian" lang="ru" hreflang="ru">Русский</a></li><li class="interlanguage-link interwiki-sr"><a href="//sr.wikipedia.org/wiki/Antitrombin" title="Antitrombin – Serbian" lang="sr" hreflang="sr">Српски / srpski</a></li><li class="interlanguage-link interwiki-sh"><a href="//sh.wikipedia.org/wiki/Antitrombin" title="Antitrombin – Serbo-Croatian" lang="sh" hreflang="sh">Srpskohrvatski / српскохрватски</a></li><li class="interlanguage-link interwiki-sv"><a href="//sv.wikipedia.org/wiki/Antitrombin" title="Antitrombin – Swedish" lang="sv" hreflang="sv">Svenska</a></li><li class="uls-p-lang-dummy"><a href="#"></a></li>					</ul>
				<div class='after-portlet after-portlet-lang'><span class="wb-langlinks-edit wb-langlinks-link"><a href="//www.wikidata.org/wiki/Q416336#sitelinks-wikipedia" title="Edit interlanguage links" class="wbc-editpage">Edit links</a></span></div>			</div>
		</div>
				</div>
		</div>
		<div id="footer" role="contentinfo">
							<ul id="footer-info">
											<li id="footer-info-lastmod"> This page was last modified on 29 April 2015, at 02:39.</li>
											<li id="footer-info-copyright">Text is available under the <a rel="license" href="//en.wikipedia.org/wiki/Wikipedia:Text_of_Creative_Commons_Attribution-ShareAlike_3.0_Unported_License">Creative Commons Attribution-ShareAlike License</a><a rel="license" href="//creativecommons.org/licenses/by-sa/3.0/" style="display:none;"></a>;
additional terms may apply.  By using this site, you agree to the <a href="//wikimediafoundation.org/wiki/Terms_of_Use">Terms of Use</a> and <a href="//wikimediafoundation.org/wiki/Privacy_policy">Privacy Policy</a>. Wikipedia® is a registered trademark of the <a href="//www.wikimediafoundation.org/">Wikimedia Foundation, Inc.</a>, a non-profit organization.</li>
									</ul>
							<ul id="footer-places">
											<li id="footer-places-privacy"><a href="//wikimediafoundation.org/wiki/Privacy_policy" title="wikimedia:Privacy policy">Privacy policy</a></li>
											<li id="footer-places-about"><a href="/wiki/Wikipedia:About" title="Wikipedia:About">About Wikipedia</a></li>
											<li id="footer-places-disclaimer"><a href="/wiki/Wikipedia:General_disclaimer" title="Wikipedia:General disclaimer">Disclaimers</a></li>
											<li id="footer-places-contact"><a href="//en.wikipedia.org/wiki/Wikipedia:Contact_us">Contact Wikipedia</a></li>
											<li id="footer-places-developers"><a href="https://www.mediawiki.org/wiki/Special:MyLanguage/How_to_contribute">Developers</a></li>
											<li id="footer-places-mobileview"><a href="//en.m.wikipedia.org/w/index.php?title=Antithrombin&amp;mobileaction=toggle_view_mobile" class="noprint stopMobileRedirectToggle">Mobile view</a></li>
									</ul>
										<ul id="footer-icons" class="noprint">
											<li id="footer-copyrightico">
							<a href="//wikimediafoundation.org/"><img src="/static/images/wikimedia-button.png" srcset="/static/images/wikimedia-button-1.5x.png 1.5x, /static/images/wikimedia-button-2x.png 2x" width="88" height="31" alt="Wikimedia Foundation"/></a>						</li>
											<li id="footer-poweredbyico">
							<a href="//www.mediawiki.org/"><img src="//en.wikipedia.org/static/1.26wmf13/resources/assets/poweredby_mediawiki_88x31.png" alt="Powered by MediaWiki" srcset="//en.wikipedia.org/static/1.26wmf13/resources/assets/poweredby_mediawiki_132x47.png 1.5x, //en.wikipedia.org/static/1.26wmf13/resources/assets/poweredby_mediawiki_176x62.png 2x" width="88" height="31" /></a>						</li>
									</ul>
						<div style="clear:both"></div>
		</div>
		<script>if(window.jQuery)jQuery.ready();</script><script>if(window.mw){
mw.loader.state({"ext.globalCssJs.site":"ready","ext.globalCssJs.user":"ready","site":"loading","user":"ready","user.groups":"ready"});
}</script>
<link rel="stylesheet" href="//en.wikipedia.org/w/load.php?debug=false&amp;lang=en&amp;modules=ext.cite.styles%7Cext.gadget.DRN-wizard%2CReferenceTooltips%2CWatchlistGreenIndicators%2Ccharinsert%2Cfeatured-articles-links%2CrefToolbar%2Cswitcher%2Cteahouse%7Cext.wikimediaBadges&amp;only=styles&amp;skin=vector&amp;*" />
<script>if(window.mw){
mw.loader.load(["ext.cite.a11y","mediawiki.toc","mediawiki.action.view.postEdit","mediawiki.user","mediawiki.hidpi","mediawiki.page.ready","mediawiki.searchSuggest","ext.cirrusSearch.loggingSchema","mmv.bootstrap.autostart","ext.imageMetrics.loader","ext.eventLogging.subscriber","ext.wikimediaEvents","ext.wikimediaEvents.statsd","ext.navigationTiming","ext.gadget.teahouse","ext.gadget.ReferenceTooltips","ext.gadget.WatchlistGreenIndicators","ext.gadget.DRN-wizard","ext.gadget.charinsert","ext.gadget.refToolbar","ext.gadget.switcher","ext.gadget.featured-articles-links","ext.visualEditor.targetLoader","schema.UniversalLanguageSelector","ext.uls.eventlogger","ext.uls.interlanguage"],null,true);
}</script>
<script>if(window.mw){
document.write("\u003Cscript src=\"//en.wikipedia.org/w/load.php?debug=false\u0026amp;lang=en\u0026amp;modules=site\u0026amp;only=scripts\u0026amp;skin=vector\u0026amp;*\"\u003E\u003C/script\u003E");
}</script>
<script>if(window.mw){
mw.config.set({"wgBackendResponseTime":110,"wgHostname":"mw1100"});
}</script>
	</body>
</html>
